<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58731</article-id><article-id pub-id-type="doi">10.7554/eLife.58731</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-187149"><name><surname>Zorrilla de San Martin</surname><given-names>Javier</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2848-7482</contrib-id><email>javier.zorrilla@icm-institute.org</email><xref ref-type="aff" rid="aff1"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187771"><name><surname>Donato</surname><given-names>Cristina</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4078-0745</contrib-id><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">†</xref></contrib><contrib contrib-type="author" id="author-187770"><name><surname>Peixoto</surname><given-names>Jérémy</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6814-9747</contrib-id><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa2">‡</xref></contrib><contrib contrib-type="author" id="author-120540"><name><surname>Aguirre</surname><given-names>Andrea</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1176-8747</contrib-id><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187772"><name><surname>Choudhary</surname><given-names>Vikash</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135845"><name><surname>De Stasi</surname><given-names>Angela Michela</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135838"><name><surname>Lourenço</surname><given-names>Joana</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5550-9291</contrib-id><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-110142"><name><surname>Potier</surname><given-names>Marie-Claude</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2462-7150</contrib-id><email>marie-claude.potier@upmc.fr</email><xref ref-type="aff" rid="aff1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund11"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-52339"><name><surname>Bacci</surname><given-names>Alberto</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3355-5892</contrib-id><email>alberto.bacci@icm-institute.org</email><xref ref-type="aff" rid="aff1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>Institut du Cerveau (ICM), CNRS UMR 7225 – Inserm U1127, Sorbonne Université</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Nelson</surname><given-names>Sacha B</given-names></name><role>Reviewing Editor</role><aff><institution>Brandeis University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Westbrook</surname><given-names>Gary L</given-names></name><role>Senior Editor</role><aff><institution>Oregon Health and Science University</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg</p></fn><fn fn-type="present-address" id="pa2"><label>‡</label><p>Institut Pasteur, Paris, France</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>12</day><month>08</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e58731</elocation-id><history><date date-type="received" iso-8601-date="2020-05-09"><day>09</day><month>05</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-08-11"><day>11</day><month>08</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Zorrilla de San Martin et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Zorrilla de San Martin et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-58731-v2.pdf"/><abstract><p>Down syndrome (DS) results in various degrees of cognitive deficits. In DS mouse models, recovery of behavioral and neurophysiological deficits using GABA<sub>A</sub>R antagonists led to hypothesize an excessive activity of inhibitory circuits in this condition. Nonetheless, whether over-inhibition is present in DS and whether this is due to specific alterations of distinct GABAergic circuits is unknown. In the prefrontal cortex of Ts65Dn mice (a well-established DS model), we found that the dendritic synaptic inhibitory loop formed by somatostatin-positive Martinotti cells (MCs) and pyramidal neurons (PNs) was strongly enhanced, with no alteration in their excitability. Conversely, perisomatic inhibition from parvalbumin-positive (PV) interneurons was unaltered, but PV cells of DS mice lost their classical fast-spiking phenotype and exhibited increased excitability. These microcircuit alterations resulted in reduced pyramidal-neuron firing and increased phase locking to cognitive-relevant network oscillations in vivo. These results define important synaptic and circuit mechanisms underlying cognitive dysfunctions in DS.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>Down syndrome is a genetic disorder caused by the presence of a third copy of chromosome 21. Affected individuals show delayed growth, characteristic facial features, altered brain development; with mild to severe intellectual disability. The exact mechanisms underlying the intellectual disability in Down syndrome are unclear, although studies in mice have provided clues. Drugs that reduce the inhibitory activity in the brain improve cognition in a mouse model of Down syndrome. This suggests that excessive inhibitory activity may contribute to the cognitive impairments.</p><p>Many different neural circuits generate inhibitory activity in the brain. These circuits contain cells called interneurons. Sub-types of interneurons act via different mechanisms to reduce the activity of neurons. Identifying the interneurons that are affected in Down syndrome would thus improve our understanding of the brain basis of the disorder.</p><p>Zorrilla de San Martin et al. compared mice with Down syndrome to unaffected control mice. The results revealed an increased activity in two types of inhibitory brain circuits in Down syndrome. The first contains interneurons called Martinotti cells. These help the brain to combine inputs from different sources. The second contains interneurons called parvalbumin-positive basket cells. These help different areas of the brain to synchronize their activity, which in turn makes it easier for those areas to exchange information.</p><p>By mapping the changes in inhibitory circuits in Down syndrome, Zorrilla de San Martin et al. have provided new insights into the biological basis of the disorder. Future studies should examine whether targeting specific circuits with pharmacological treatments could ultimately help reduce the associated impairments.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>down syndrome</kwd><kwd>interneuron</kwd><kwd>gamma oscillations</kwd><kwd>prefrontal cortex</kwd><kwd>synaptic transmission</kwd><kwd>ts65dn</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007353</institution-id><institution>Fondation Jérôme Lejeune</institution></institution-wrap></funding-source><award-id>#1790</award-id><principal-award-recipient><name><surname>Zorrilla de San Martin</surname><given-names>Javier</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>ICM - Institut du Cerveau</institution></institution-wrap></funding-source><award-id>BBT-MOCONET</award-id><principal-award-recipient><name><surname>Potier</surname><given-names>Marie-Claude</given-names></name><name><surname>Bacci</surname><given-names>Alberto</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Fondation Recherche Medicale - Equipe FRM</institution></institution-wrap></funding-source><award-id>DEQ20150331684</award-id><principal-award-recipient><name><surname>Bacci</surname><given-names>Alberto</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009670</institution-id><institution>National Alliance for Research on Schizophrenia and Depression</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Bacci</surname><given-names>Alberto</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Fondation Recherche Medicale - Equipe FRM</institution></institution-wrap></funding-source><award-id>EQU201903007860</award-id><principal-award-recipient><name><surname>Bacci</surname><given-names>Alberto</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche - ANR</institution></institution-wrap></funding-source><award-id>ANR-13-BSV4-0015-01</award-id><principal-award-recipient><name><surname>Bacci</surname><given-names>Alberto</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche - ANR</institution></institution-wrap></funding-source><award-id>ANR-17-CE16-0026-01</award-id><principal-award-recipient><name><surname>Bacci</surname><given-names>Alberto</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche - ANR</institution></institution-wrap></funding-source><award-id>ANR-18-CE16-0001-01</award-id><principal-award-recipient><name><surname>Bacci</surname><given-names>Alberto</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche - ANR</institution></institution-wrap></funding-source><award-id>ANR-10-IAIHU-06</award-id><principal-award-recipient><name><surname>Potier</surname><given-names>Marie-Claude</given-names></name><name><surname>Bacci</surname><given-names>Alberto</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche - ANR</institution></institution-wrap></funding-source><award-id>ANR-12-EMMA-0010</award-id><principal-award-recipient><name><surname>Potier</surname><given-names>Marie-Claude</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche - ANR</institution></institution-wrap></funding-source><award-id>ANR-16-CE16-0007-02</award-id><principal-award-recipient><name><surname>Potier</surname><given-names>Marie-Claude</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Distinct intrinsic excitability and synaptic dysfunctions in specific cortical inhibitory circuits lead to abnormal network activity in a mouse model of Down syndrome.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Down syndrome (DS) is a condition caused by full or partial trisomy of human chromosome 21, characterized by various physical and neurological features including mild to severe intellectual disability (<xref ref-type="bibr" rid="bib4">Antonarakis et al., 2020</xref>). Individuals with DS present important deficits in cognitive tasks known to depend on the anatomical and functional integrity of the frontal lobe (<xref ref-type="bibr" rid="bib37">Lee et al., 2015</xref>). Moreover, DS is also associated with other CNS-mediated phenotypes, including an ultra-high risk for developing Alzheimer’s disease and high rates of autism for which the mechanisms are unknown (<xref ref-type="bibr" rid="bib19">DiGuiseppi et al., 2010</xref>; <xref ref-type="bibr" rid="bib58">Wiseman et al., 2015</xref>). Interventions to ameliorate DS-mediated cognitive dysfunctions are limited. The development of interventions for this vulnerable group of individuals can be achieved through a better understanding of the mechanisms underlying a core feature of DS, such as intellectual disability.</p><p>Importantly, mouse models of DS recapitulate several cognitive deficits of this condition (<xref ref-type="bibr" rid="bib29">Herault et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Olmos-Serrano et al., 2016b</xref>). One of the best-characterized mouse models is the Ts65Dn mouse line (herein referred to as Ts), which carries a partial trisomy of a segment of the mouse chromosome 16 (<xref ref-type="bibr" rid="bib16">Davisson et al., 1993</xref>). Ts mice recapitulate several dysfunctions present in DS individuals, such as reduced birthweight, male sterility, abnormal facial appearance and several cognitive impairments, including executive functions, such as working memory and cognitive flexibility (<xref ref-type="bibr" rid="bib44">Olmos-Serrano et al., 2016b</xref>).</p><p>Recovery of behavioral and neurophysiological deficits underlying cognitive impairments using GABA<sub>A</sub> receptor blockers led to the hypothesis that intellectual deficits in DS are produced by an excessive activity of inhibitory circuits (<xref ref-type="bibr" rid="bib22">Fernandez et al., 2007</xref>; <xref ref-type="bibr" rid="bib59">Zorrilla de San Martin et al., 2018</xref>). Nonetheless, direct evidence for over-inhibition in DS is lacking. Moreover, given the anatomical, molecular and functional diversity of cortical inhibitory neurons (<xref ref-type="bibr" rid="bib54">Tremblay et al., 2016</xref>), the functional implications of this hypothesis at the network level, as well as the involvement of specific GABAergic circuits remain obscure.</p><p>Executive functions depend on the integrity of the prefrontal cortex (PFC), which plays an essential role in the synchronization of task-relevant, large-scale neuronal activity (<xref ref-type="bibr" rid="bib28">Helfrich and Knight, 2016</xref>). An important network correlate of this synchronization is represented by neuronal oscillations: rhythmic fluctuations of the electrical activity of single neurons, local neuronal populations and multiple neuronal assemblies, distributed across different brain regions (<xref ref-type="bibr" rid="bib9">Buzsáki and Wang, 2012</xref>). Oscillations are the result of a balanced and coordinated activity of excitatory pyramidal neurons (PNs) and a rich diversity of inhibitory neurons that use γ-aminobutiric acid (GABA) as neurotransmitter. In particular, parvalbumin (PV)-positive inhibitory interneurons form synapses onto the perisomatic region of PNs. PV cells thus tightly control PN spiking activity and drive network oscillations in the γ-frequency range (30–100 Hz) (<xref ref-type="bibr" rid="bib9">Buzsáki and Wang, 2012</xref>). γ-Oscillations are necessary for several PFC cognitive functions, such as sustained attention (<xref ref-type="bibr" rid="bib34">Kim et al., 2016b</xref>) and cognitive flexibility (<xref ref-type="bibr" rid="bib14">Cho et al., 2015</xref>). Conversely, Martinotti cells (MCs) are somatostatin (SST)-positive interneurons that inhibit distal dendrites of PNs, thereby controlling the integration of distal dendritic glutamatergic synaptic inputs originating from different regions of the brain (<xref ref-type="bibr" rid="bib54">Tremblay et al., 2016</xref>). Dendritic integration of multi-pathway inputs is necessary for working memory (<xref ref-type="bibr" rid="bib1">Abbas et al., 2018</xref>; <xref ref-type="bibr" rid="bib33">Kim et al., 2016a</xref>). Therefore, PV interneurons and MCs represent two major cortical inhibitory circuits, characterized by a precise division of labor during cortical activity. Both forms of inhibition were shown to be involved in the entrainment of network oscillations (<xref ref-type="bibr" rid="bib10">Cardin et al., 2009</xref>; <xref ref-type="bibr" rid="bib13">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="bib52">Sohal et al., 2009</xref>; <xref ref-type="bibr" rid="bib56">Veit et al., 2017</xref>) and in the cognitive performance during medial (m)PFC-dependent tasks (<xref ref-type="bibr" rid="bib1">Abbas et al., 2018</xref>; <xref ref-type="bibr" rid="bib14">Cho et al., 2015</xref>; <xref ref-type="bibr" rid="bib15">Cummings and Clem, 2020</xref>). In particular, inhibition from SST interneurons plays a crucial role in mPFC-dependent memory (<xref ref-type="bibr" rid="bib1">Abbas et al., 2018</xref>; <xref ref-type="bibr" rid="bib15">Cummings and Clem, 2020</xref>).</p><p>Broad-spectrum GABA<sub>A</sub>R antagonists are not clinically viable, as they can yield undesired seizure-like activity and/or anxiety. Interestingly, however, treatment of Ts mice with selective and partial negative allosteric modulators of α5-containing GABA<sub>A</sub>Rs (α5 inverse agonist or α5IA) reverse cognitive behavioral and long-term synaptic plasticity deficits in DS mice (<xref ref-type="bibr" rid="bib8">Braudeau et al., 2011</xref>; <xref ref-type="bibr" rid="bib20">Duchon et al., 2020</xref>; <xref ref-type="bibr" rid="bib40">Martínez-Cué et al., 2013</xref>; <xref ref-type="bibr" rid="bib49">Schulz et al., 2019</xref>). Importantly, neocortical dendritic synaptic inhibition of PNs from MCs relies on α5-containing GABA<sub>A</sub>Rs (<xref ref-type="bibr" rid="bib3">Ali and Thomson, 2008</xref>). The preference for this specific GABA<sub>A</sub>R subunit was also recently demonstrated at the equivalent hippocampal dendritic inhibitory circuit (<xref ref-type="bibr" rid="bib49">Schulz et al., 2019</xref>; <xref ref-type="bibr" rid="bib48">Schulz et al., 2018</xref>), raising the question of whether dendritic inhibition is specifically altered in DS.</p><p>Here we found that the dendritic synaptic inhibitory loop formed by MCs and PNs was strongly potentiated in Ts mice, with no alteration of either cell-type excitability. Conversely, the perisomatic synaptic inhibitory loop from PV cells onto PN cell bodies was unaffected in Ts mice. Strikingly, however, PV-cell excitability was strongly altered: these interneurons did not display their typical fast-spiking behavior and exhibited enhanced excitability. At the network level in vivo, these inhibitory microcircuit-specific alterations resulted in significant reduction of putative PN firing, which in turn was more tuned to β- and low γ-oscillations (10–60 Hz). These results confirm over-inhibition in DS, and reveal unexpected functional alterations of specific GABAergic circuits in this condition.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Synaptic enhancement of dendritic inhibition in DS</title><p>Cognitive and synaptic plasticity deficits in Ts mice can be successfully treated by systemic application of a selective negative allosteric modulator of α5-containing GABA<sub>A</sub>Rs, α5IA (<xref ref-type="bibr" rid="bib8">Braudeau et al., 2011</xref>; <xref ref-type="bibr" rid="bib20">Duchon et al., 2020</xref>; <xref ref-type="bibr" rid="bib40">Martínez-Cué et al., 2013</xref>; <xref ref-type="bibr" rid="bib49">Schulz et al., 2019</xref>). α5-GABA<sub>A</sub>Rs are expressed at PN synapses originating from dendrite-targeting interneurons: MCs in the neocortex (<xref ref-type="bibr" rid="bib3">Ali and Thomson, 2008</xref>) and O-LM in the hippocampus (<xref ref-type="bibr" rid="bib48">Schulz et al., 2018</xref>). We therefore tested whether dendritic inhibition of PNs by MCs are affected in Ts mice.</p><p>We crossed Ts65Dn with GFP-X98 mice, which in the barrel cortex were shown to bias GFP expression in MCs (<xref ref-type="bibr" rid="bib39">Ma et al., 2006</xref>). Accordingly, in the mPFC of these mice, GFP was expressed by a subset of SST-positive interneurons (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a</xref>), exhibiting a widely branched axonal plexus in L1, characteristic of dendrite-targeting inhibitory MCs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1b,c</xref>). Using dual whole-cell patch-clamp recordings in acute mPFC slices, we isolated unitary inhibitory postsynaptic currents (uIPSCs) in MC-PN connected pairs (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). We found that dendritic MC-PN synaptic inhibition relied on α5-containing GABA<sub>A</sub>Rs in both Ts and control, euploid (Eu) mice. Indeed, in both genotypes, bath application of the selective negative allosteric modulator of α5-containing GABA<sub>A</sub>Rs, α5IA (100 nM; <xref ref-type="bibr" rid="bib53">Sternfeld et al., 2004</xref>), produced a significant reduction of uIPSCs that was close to the maximal potency of the drug (~40%; <xref ref-type="bibr" rid="bib17">Dawson et al., 2006</xref>; <xref ref-type="fig" rid="fig1">Figure 1b</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). IPSC rise and decay times were not affected by α5IA application (data not shown).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Synaptic enhancement of dendritic inhibition in DS.</title><p>(<bold>a</bold>) Schematic of cortical inhibitory circuits involving PV interneurons, MCs and PNs. (<bold>b</bold>) Representative voltage-clamp current traces of uIPSCs recorded in MC-PN connected pair in a Eu (top) and a Ts (bottom) mouse, before (Ctrl) and after (α5IA) application of the α5-GABA<sub>A</sub>R inverse agonist α5IA (100 nM). Shown are averages of 50 traces. Right, bottom: population data of uIPSC amplitude block by α5IA in Eu and Ts mice. (<bold>c</bold>) Top: Representative traces of uIPSCs (lower traces) elicited by a train of 5 presynaptic action currents (50 Hz) in the MC (upper traces). Eu: individual (gray) and average (black) traces; Ts: individual (light blue) and average (blue) traces. Bottom panels: population data of uIPSC amplitude (p=0.0094, Mann-Whitney U-test), failure rate of the postsynaptic response evoked by the first action potential of the train (p=0.0201, Mann-Whitney U-test) and total charge, transferred during the 5 APs train (Q, p=0.006, Mann-Whitney U-test; n = 11 and 15 pairs for Eu and Ts, respectively). (<bold>d</bold>) Same as in <bold>c</bold>, but for glutamatergic uEPSCs triggered by action currents in presynaptic PNs and recorded in postsynaptic MCs (Amplitude: p=0.0398, Mann-Whitney U-test; Failure Rate: p=0.0107, Mann-Whitney U-test; Q: p=0.0157, Students T-test; n = 7 for both, Eu and Ts).</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Synaptic properties of the dendritic inhibitory loop.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58731-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>GFP positive interneurons in the prefrontal cortex of Ts::X98 mice are Martinotti cells.</title><p>(<bold>a</bold>) Immunostaining using anti-GFP (green) and anti-SST (red) antibodies in the mPFC. Note the co-localization of both markers. Arrows point to GFP and SST. (<bold>b</bold>) Biocytin-filled GFP-positive interneuron revealed with Texas-red coupled to streptavidin. Note the wide extension of the axonal plexus of Ts::X98 GFP-positive neurons in layer 1, typical of Martinotti cells. (<bold>c</bold>) Top: Reconstructed morphology of the biocytin-filled cell of b and bottom: the polar histograms of its axonal (blue) and dendritic (pink) densities.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Abnormal IPSC kinetics in DS.</title><p>(<bold>a</bold>) Representative unitary inhibitory synaptic currents recorded at the MC to PN synapse. Inset: detail of the rise phase. (<bold>b</bold>) Population data of the rise time (left, p=0.02448, Mann-Whitney U test) and decay time (right, p=0.1488, Mann-Whitney U test, n = 18 and 18 for Eu and Ts, respectively).</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>MC to PN synapse kinetics.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58731-fig1-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Short term plasticity of the dendritic inhibitory loop in Ts.</title><p>(<bold>a</bold>) Schematic representation of the inhibitory synapse of the cortical dendritic inhibitory loop mediated by MCs. (<bold>b</bold>) Normalized amplitude of IPSCs evoked by a 5-AP train applied at 50 Hz to the presynaptic MC (Two-Way ANOVA genotype factor: F<sub>(1, 150)</sub>=4.298, p=0.0399). (<bold>c</bold>) Failure rate of synaptic responses evoked by each AP of the train (Two-Way ANOVA genotype factor: F<sub>(1,140)</sub>=35.28, p&lt;0.0001, n = 13 and 17 pairs for Eu and Ts, respectively). (<bold>d</bold>) Schematic representation of the excitatory synapse between PN and MCs. (<bold>e</bold>) Normalized amplitude of EPSCs evoked by a 5-AP train applied at 50 Hz to the presynaptic PN (Two-Way ANOVA genotype factor: F<sub>(1,11)</sub>=0.1205, p=0.7350). (<bold>f</bold>) Failure rate of synaptic responses evoked by each AP of the train (Two-Way ANOVA genotype factor: F<sub>(1,11)</sub>=7.396, p=0.0200, n = 7 and 6 pairs for Eu and Ts, respectively).</p><p><supplementary-material id="fig1s3sdata1"><label>Figure 1—figure supplement 3—source data 1.</label><caption><title>Short term plasticity of the dendritic inhibitory loop.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58731-fig1-figsupp3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig1-figsupp3-v2.tif"/></fig></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>MC to PN synaptic efficiency evaluation.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="8" valign="middle">Dendritic Inhibition</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="center" valign="middle"/><th align="center" valign="middle"/><th align="center" colspan="4" valign="middle">Euploid</th><th align="center" colspan="4" style="author-callout-style-b1" valign="middle">Ts65Dn</th><th align="center" valign="middle"/><th align="center" valign="middle"/></tr><tr><th align="center" valign="middle"/><th align="center" valign="middle"/><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">test</th><th align="center" valign="middle">p value</th></tr></thead><tbody><tr><td align="center" rowspan="6" valign="middle">MC-PN IPSC</td><td align="center" valign="middle">Amplitude (pA)</td><td align="center" valign="middle">29.89</td><td align="center" valign="middle">20.24</td><td align="center" valign="middle">52.98</td><td align="center" valign="middle">11</td><td align="center" valign="middle">97.09</td><td align="center" valign="middle">54.49</td><td align="center" valign="middle">135.86</td><td align="center" valign="middle">15</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0095</td></tr><tr><td align="center" valign="middle">Failure Rate</td><td align="center" valign="middle">0.20</td><td align="center" valign="middle">0.11</td><td align="center" valign="middle">0.25</td><td align="center" valign="middle">11</td><td align="center" valign="middle">0.00</td><td align="center" valign="middle">0.00</td><td align="center" valign="middle">0.13</td><td align="center" valign="middle">15</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0201</td></tr><tr><td align="center" valign="middle">Charge (pC)</td><td align="center" valign="middle">1.28</td><td align="center" valign="middle">0.96</td><td align="center" valign="middle">1.84</td><td align="center" valign="middle">11</td><td align="center" valign="middle">6.86</td><td align="center" valign="middle">2.96</td><td align="center" valign="middle">8.32</td><td align="center" valign="middle">15</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.00595</td></tr><tr><td align="center" valign="middle">α5IA % block</td><td align="center" valign="middle">41</td><td align="center" valign="middle">24.20</td><td align="center" valign="middle">57.20</td><td align="center" valign="middle">4</td><td align="center" valign="middle">57.4</td><td align="center" valign="middle">33.10</td><td align="center" valign="middle">73.10</td><td align="center" valign="middle">6</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.2278</td></tr><tr><td align="center" valign="middle">Rise Time (ms)</td><td align="center" valign="middle">1.20</td><td align="center" valign="middle">1.00</td><td align="center" valign="middle">1.80</td><td align="center" valign="middle">18</td><td align="center" valign="middle">1.70</td><td align="center" valign="middle">1.50</td><td align="center" valign="middle">2.10</td><td align="center" valign="middle">18</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.02448</td></tr><tr><td align="center" valign="middle">Decay Time (ms)</td><td align="center" valign="middle">15.60</td><td align="center" valign="middle">10.00</td><td align="center" valign="middle">19.40</td><td align="center" valign="middle">18</td><td align="center" valign="middle">17.10</td><td align="center" valign="middle">15.00</td><td align="center" valign="middle">21.70</td><td align="center" valign="middle">18</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.1488</td></tr></tbody></table><table-wrap-foot><fn><p>Median: quantile 50; Q1: quantile 25; Q3: quantile 75; n: number of cells; IPSC: Inhibitory postsynaptic current.</p></fn></table-wrap-foot></table-wrap><p>Interestingly, MC-mediated uIPSC amplitudes were significantly larger and failure rate of synaptic responses evoked by the first action potential was significantly smaller in Ts compared to Eu mice. Moreover, the total amount of synaptic charge (Q) transferred during a train of 5 action potentials was near 5-fold larger in Ts than in Eu (<xref ref-type="fig" rid="fig1">Figure 1c</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). MC-PN uIPSCs exhibited faster rise time in Ts as compared to Eu mice. Yet, uIPSC decay time-constants were similar in the two genotypes (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). We then examined glutamatergic recruitment of MCs by PNs and found that it was stronger in Ts than Eu mice. Unitary excitatory postsynaptic currents (uEPSCs) in connected PN-MC pairs exhibited larger amplitude, lower failure rate and larger charge transfer in Ts than Eu mice (<xref ref-type="fig" rid="fig1">Figure 1d</xref>, <xref ref-type="table" rid="table2">Table 2</xref>).</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>PN to MC synaptic efficiency evaluation.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="8" valign="middle">Dendritic Inhibition</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="4" valign="middle">Euploid</th><th align="center" colspan="4" style="author-callout-style-b1" valign="middle">Ts65Dn</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="left" valign="middle"/><th align="left" valign="middle"/><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">test</th><th align="center" valign="middle">p value</th></tr></thead><tbody><tr><td align="center" rowspan="3" valign="middle">PN-MC EPSC</td><td align="center" valign="middle">Amplitude (pA)</td><td align="center" valign="middle">5.36</td><td align="center" valign="middle">2.13</td><td align="center" valign="middle">7.46</td><td align="center" valign="middle">7</td><td align="center" valign="middle">18.66</td><td align="center" valign="middle">11.44</td><td align="center" valign="middle">28.21</td><td align="center" valign="middle">7</td><td align="center" valign="middle">T-test</td><td align="center" valign="middle">0.0106</td></tr><tr><td align="center" valign="middle">Failure Rate</td><td align="center" valign="middle">0.87</td><td align="center" valign="middle">0.81</td><td align="center" valign="middle">0.93</td><td align="center" valign="middle">7</td><td align="center" valign="middle">0.52</td><td align="center" valign="middle">0.39</td><td align="center" valign="middle">0.71</td><td align="center" valign="middle">7</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0126</td></tr><tr><td align="center" valign="middle">Charge (pC)</td><td align="center" valign="middle">0.27</td><td align="center" valign="middle">0.22</td><td align="center" valign="middle">0.31</td><td align="center" valign="middle">7</td><td align="center" valign="middle">0.87</td><td align="center" valign="middle">0.53</td><td align="center" valign="middle">1.13</td><td align="center" valign="middle">7</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0073</td></tr></tbody></table><table-wrap-foot><fn><p>Median: quantile 50; Q1: quantile 25; Q3: quantile 75; n: number of cells; EPSC: Excitatory postsynaptic current.</p></fn></table-wrap-foot></table-wrap><p>Importantly, in both Ts and Eu mice, short-term dynamics of MC-PN GABAergic and PN-MC glutamatergic synaptic transmission were depressing and facilitating, respectively. However, short-term depression of MC-dependent dendritic inhibition onto PNs was more pronounced in Ts than Eu mice (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). Conversely, glutamatergic recruitment of MCs displayed the classical strong facilitating characteristics (<xref ref-type="bibr" rid="bib51">Silberberg and Markram, 2007</xref>) with no differences in short-term uEPSC dynamics in the two genotypes (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). Regardless of whether unitary synaptic responses exhibited significant alterations of short-term plasticity, both MC-PN uIPSCs and PN-MC uEPSCs of Ts mice were characterized by a significant decrease of failure rate in all synaptic responses within the train. These results on short-term plasticity suggest that, in Ts mice, GABAergic and glutamatergic synapses involved in the PN-MC-PN dendritic inhibitory loop increased their efficacy using different pre- and postsynaptic strategies.</p><p>Overall, these results indicate that the dendritic inhibitory loop involving MCs and PNs is strengthened in Ts mice. Both output GABAergic synapses from MCs and their recruitment by local glutamatergic synapses were stronger and more reliable in Ts mice, as compared to their euploid littermates.</p></sec><sec id="s2-2"><title>Excitability and morphology of MCs and PNs in Ts mice</title><p>Alteration of the MC-PN-MC synaptic loop can be associated to changes in intrinsic excitability and morphological features. We therefore tested whether passive properties, single action potentials and firing dynamics were altered in both PNs and MCs. In addition, we filled neurons with biocytin and we quantified their dendritic and axonal arborizations. Input-output spiking activity of both PNs and MCs was assessed by injecting increasing depolarizing 2 s-long currents. The firing frequency vs. injected current (<italic>f-i</italic>) curve was similar in both cell types in Eu and Ts mice (<xref ref-type="fig" rid="fig2">Figure 2a,b</xref>; <xref ref-type="table" rid="table3">Tables 3</xref>–<xref ref-type="table" rid="table4">4</xref>). Furthermore, single-action potential features, and passive properties were similar in both genotypes except for a small but significant increase in action potential threshold of Ts PNs (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplements 1</xref> and <xref ref-type="fig" rid="fig2s2">2</xref>; <xref ref-type="table" rid="table5">Tables 5</xref>–<xref ref-type="table" rid="table6">6</xref>). Importantly, the density of GFP-expressing MCs, and, in general, of SST-positive interneurons was similar in both genotypes (<xref ref-type="fig" rid="fig2">Figure 2c</xref>; <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Normal excitability and morphology of PNs and MCs in Ts mice.</title><p>(<bold>a</bold>) Representative current-clamp traces of membrane potential responses to injections of current steps of increasing amplitude applied to PNs (above) and MCs (below) from Eu (gray) and Ts (blue) mice. (<bold>b</bold>) Spiking frequency as function of injected current. Population data from PNs (left, genotype factor F<sub>(1, 598)</sub>=3.444, p=0.064, two-way ANOVA; n = 25 and 23 cells for Eu and Ts, respectively) and MCs (right, genotype factor F<sub>(1, 660)</sub>=0.004960, p=0.9439, two-way ANOVA; n = 26 and 20 cells for Eu and Ts, respectively). (<bold>c</bold>) Count of MC somas in the mPFC of Eu and Ts mice. Left: epifluorescence images of immuno-labeled GFP-expressing MCs in Ts::X98 coronal slices. Right: population data for both Eu and Ts. (<bold>d</bold>) Representative reconstruction of biocytin filled L2/3 MCs from Eu and Ts mice. Gray: somatodendritic region, red: axon. (<bold>e</bold>) Scholl analysis of MC axonal and dendritic length between concentric circles of increasing radial steps of 10 µm. (<bold>f</bold>) Population data of total axonal (left) and dendritic (right) length. (<bold>e,f</bold>) n = 18 and 8 neurons for Eu and Ts, respectively. (<bold>g</bold>) Representative reconstruction of biocytin filled PNs from Eu and Ts mice. Gray: somatodendritic region (including apical and basal dendrites), red: axon. (<bold>h–i</bold>) same as in e-f, but for apical and basal dendrites of PNs (F <sub>(1, 25)</sub>=2.487, p=0.1273 2-way ANOVA for apical dendrites; F <sub>(1, 25)</sub>=0.3521, p=0.5583 2-way ANOVA for basal dendrites). (<bold>h,i</bold>) n = 14 and 13 neurons for Eu and Ts, respectively. (<bold>c,f,i</bold>) Boxplots represent median, percentiles 25 and 75 and whiskers are percentiles 5 and 95. Points represent values from individual synapses (<bold>b,c</bold>), mice (<bold>f</bold>), neurons (<bold>i,l</bold>). *: p&lt;0.05; **: p&lt;0.01.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Excitability and morphology of PNs and MCs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58731-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Single action potential and passive properties are normal Ts mPFC PNs.</title><p>(<bold>a</bold>) AP thresholds estimated as the voltage at which the derivative of Vm as function of time (dV/dt) reaches the limit of 10 mV/ms. Eu: −41 mV, −45–39 mV (n = 23 cells) and Ts: −40, −41–39 mV mV (n = 25 cells; Mann-Whitney U-test, p=0.0453). (<bold>b</bold>) AP amplitude measured as the difference between Vm at threshold and Vm at peak Eu: 84, 75–86 mV (n = 23 cells) and Ts: 82, 69–85 mV (n = 25 cells; Mann-Whitney U-test, p=0.37486). (<bold>c</bold>) AP width. Eu: 1.2, 1–1.6 ms (n = 23 cells) and Ts: 1.2, 1–1.6 ms (n = 25 cells; p=0.74125, Mann-Whitney U-test). (<bold>d</bold>) Resting membrane potential was also not significantly different between genotypes. Eu: −76, −79–72 mV (n = 23 cells) and Ts: −73, −78–69 mV (n = 25 cells; p=0.74125, Mann-Whitney U-test). (<bold>e</bold>) Input resistance, Eu: 255, 139–378 MΩ (n = 23 cells), Ts: 178, 86–316 MΩ (n = 25 cells, p=0.05918, Mann-Whitney U-test). (<bold>f</bold>) Decay tau of the membrane Eu: 37, 28–48 (n = 23 cells), Ts: 40, 27–47 (n = 25 cells, p=0.90665, Mann-Whitney U-test). Boxplots: represent median, percentiles 25 and 75 and whiskers are percentiles 5 and 95. Individual points represent average values from individual cells.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Singleaction potentialand passive properties of mPFC PNs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58731-fig2-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Active and passive properties are normal in mPFC MCs from Ts65Dn mice.</title><p>(<bold>a</bold>) AP thresholds estimated as the voltage at which the derivative of Vm as function of time (dV/dt) reaches the limit of 10 mV/ms. Eu: −46, −52–42 (n = 23 cells); Ts: −43, −45–42 (n = 25 cells, p=0.09877, Mann-Whitney U-test). (<bold>b</bold>) AP amplitude measured as the difference between Vm at threshold and Vm at peak Eu: 79, 63–85 mV (n = 26 cells), Ts: 82, 69–85 mV (n = 20, p=0.07267, Mann-Whitney U-test). (<bold>c</bold>) AP width. Eu: 1.2, 0.9–1.6 ms (n = 26 cells), Ts: 1.2, 0.9–1.6 ms (n = 20 cells, p=0.8680, Mann-Whitney U-test). (<bold>d</bold>) Resting membrane potential. Eu: −66, −70–63 (n = 26 cells), Ts: −64, −67–62 (n = 20 cells, p=0.0566, Mann-Whitney U-test). (<bold>e</bold>) Input resistance, Eu: 238, 183–382 MΩ (n = 26 cells), Ts: 207, 176–282 MΩ (n = 20 cells, p=0.57205, Mann-Whitney U-test). (<bold>f</bold>) Decay tau of the membrane Eu: 27, 22–41 (n = 26 cells), Ts: 33, 29–52 (n = 20 cells, p=0.14067, Mann-Whitney U-test). Boxplots: represent median, percentiles 25 and 75 and whiskers are percentiles 5 and 95. Individual points represent average values from each recorded synaptic connection.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Singleaction potentialand passive properties of mPFC MCs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58731-fig2-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Normal SST-positive interneurons density in the mPFC of Ts mice.</title><p>(<bold>a</bold>) Representative fluorescence micrographs illustrating SST (red, left) and GFP (green, middle) immunostaining in Eu and Ts mice. Right column: merge of red and green channel (<bold>b</bold>) Quantification of SST-positive cells density in mPFC L2/3 from Eu and Ts Ts::X98 mice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig2-figsupp3-v2.tif"/></fig></fig-group><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>PNs excitability.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="4" valign="middle">Euploid</th><th align="center" colspan="4" style="author-callout-style-b1" valign="middle">Ts65Dn</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="left" valign="middle"/><th align="left" valign="middle"/><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">test</th><th align="center" valign="middle">p value</th></tr></thead><tbody><tr><td align="center" rowspan="2" valign="middle">Excitability</td><td align="center" valign="middle">InjCurr50 (pA)</td><td align="center" valign="middle">21.6</td><td align="center" valign="middle">19.5</td><td align="center" valign="middle">24.4</td><td align="center" valign="middle">12</td><td align="center" valign="middle">18.9</td><td align="center" valign="middle">15.9</td><td align="center" valign="middle">24.6</td><td align="center" valign="middle">11</td><td align="center" valign="middle">T-test</td><td align="center" valign="middle">0.6081</td></tr><tr><td align="center" valign="middle">Max Spiking Rate (Hz)</td><td align="center" valign="middle">112.4</td><td align="center" valign="middle">91.9</td><td align="center" valign="middle">155.0</td><td align="center" valign="middle">12</td><td align="center" valign="middle">124.5</td><td align="center" valign="middle">101.0</td><td align="center" valign="middle">178.2</td><td align="center" valign="middle">11</td><td align="center" valign="middle">T-test</td><td align="center" valign="middle">0.4500</td></tr></tbody></table><table-wrap-foot><fn><p>Median: quantile 50; Q1: quantile 25; Q3: quantile 75; n: number of cells; InjCurr50: amount of current injected to reach 50% of the maximal spiking rate.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table4" position="float"><label>Table 4.</label><caption><title>MCs excitability.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="4" valign="middle">Euploid</th><th align="center" colspan="4" style="author-callout-style-b1" valign="middle">Ts65Dn</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="left" valign="middle"/><th align="left" valign="middle"/><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">test</th><th align="center" valign="middle">p value</th></tr></thead><tbody><tr><td align="center" rowspan="2" valign="middle">Excitability</td><td align="center" valign="middle">InjCurr50 (pA)</td><td align="center" valign="middle">40.9</td><td align="center" valign="middle">26.9</td><td align="center" valign="middle">50.4</td><td align="center" valign="middle">25</td><td align="center" valign="middle">48.9</td><td align="center" valign="middle">25.4</td><td align="center" valign="middle">70.2</td><td align="center" valign="middle">20</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.6073</td></tr><tr><td align="center" valign="middle">Max Spiking Rate (Hz)</td><td align="center" valign="middle">101.8</td><td align="center" valign="middle">68.3</td><td align="center" valign="middle">124.0</td><td align="center" valign="middle">25</td><td align="center" valign="middle">86.5</td><td align="center" valign="middle">63.2</td><td align="center" valign="middle">109.7</td><td align="center" valign="middle">20</td><td align="center" valign="middle">T-test</td><td align="center" valign="middle">0.4436</td></tr></tbody></table><table-wrap-foot><fn><p>Median: quantile 50; Q1: quantile 25; Q3: quantile 75; n: number of cells; InjCurr50: amount of current injected to reach 50% of the maximal spiking rate.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table5" position="float"><label>Table 5.</label><caption><title>PNs passive and action potential (AP) properties.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="4" valign="middle">Euploid</th><th align="center" colspan="4" style="author-callout-style-b1" valign="middle">Ts65Dn</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="left" valign="middle"/><th align="left" valign="middle"/><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">test</th><th align="center" valign="middle">p value</th></tr></thead><tbody><tr><td align="center" rowspan="3" valign="middle">Passive properties</td><td align="center" valign="middle">Vrest (mV)</td><td align="center" valign="middle">-76</td><td align="center" valign="middle">-79</td><td align="center" valign="middle">-72</td><td align="center" valign="middle">25</td><td align="center" valign="middle">-73</td><td align="center" valign="middle">-78</td><td align="center" valign="middle">-69</td><td align="center" valign="middle">22</td><td align="center" valign="middle">T-test</td><td align="center" valign="middle">0.2473</td></tr><tr><td align="center" valign="middle">Ri (MΩ)</td><td align="center" valign="middle">255</td><td align="center" valign="middle">139</td><td align="center" valign="middle">378</td><td align="center" valign="middle">25</td><td align="center" valign="middle">178</td><td align="center" valign="middle">86</td><td align="center" valign="middle">316</td><td align="center" valign="middle">22</td><td align="center" valign="middle">T-test</td><td align="center" valign="middle">0.7185</td></tr><tr><td align="center" valign="middle">Tau memb (ms)</td><td align="center" valign="middle">36.5</td><td align="center" valign="middle">28.1</td><td align="center" valign="middle">47.9</td><td align="center" valign="middle">25</td><td align="center" valign="middle">39.7</td><td align="center" valign="middle">26.8</td><td align="center" valign="middle">46.9</td><td align="center" valign="middle">22</td><td align="center" valign="middle">T-test</td><td align="center" valign="middle">0.5790</td></tr><tr><td align="center" rowspan="3" valign="middle">AP properties</td><td align="center" valign="middle">Threshold (mV)</td><td align="center" valign="middle">-40.9</td><td align="center" valign="middle">-45.6</td><td align="center" valign="middle">-39.2</td><td align="center" valign="middle">25</td><td align="center" valign="middle">-39.6</td><td align="center" valign="middle">-40.8</td><td align="center" valign="middle">-38.5</td><td align="center" valign="middle">22</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0453</td></tr><tr><td align="center" valign="middle">Amplitude (mV)</td><td align="center" valign="middle">83.6</td><td align="center" valign="middle">75.1</td><td align="center" valign="middle">85.8</td><td align="center" valign="middle">25</td><td align="center" valign="middle">82.5</td><td align="center" valign="middle">69.2</td><td align="center" valign="middle">85.5</td><td align="center" valign="middle">22</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.3749</td></tr><tr><td align="center" valign="middle">Width (ms)</td><td align="center" valign="middle">1.2</td><td align="center" valign="middle">1.0</td><td align="center" valign="middle">1.6</td><td align="center" valign="middle">25</td><td align="center" valign="middle">1.2</td><td align="center" valign="middle">1.0</td><td align="center" valign="middle">1.6</td><td align="center" valign="middle">22</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.7413</td></tr></tbody></table><table-wrap-foot><fn><p>Median: quantile 50; Q1: quantile 25; Q3: quantile 75; n: number of cells; Vrest: Resting membrane potential; Ri : input resistance.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table6" position="float"><label>Table 6.</label><caption><title>MCs passive and action potential (AP) properties.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="4" valign="middle">Euploid</th><th align="center" colspan="4" style="author-callout-style-b1" valign="middle">Ts65Dn</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="left" valign="middle"/><th align="left" valign="middle"/><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">test</th><th align="center" valign="middle">p value</th></tr></thead><tbody><tr><td align="center" rowspan="3" valign="middle">Passive properties</td><td align="center" valign="middle">Vrest (mV)</td><td align="center" valign="middle">-66</td><td align="center" valign="middle">-70</td><td align="center" valign="middle">-63</td><td align="center" valign="middle">26</td><td align="center" valign="middle">-64</td><td align="center" valign="middle">-67</td><td align="center" valign="middle">-62</td><td align="center" valign="middle">20</td><td align="center" valign="middle">T-test</td><td align="center" valign="middle">0.0566</td></tr><tr><td align="center" valign="middle">Ri (MΩ)</td><td align="right" valign="bottom">238</td><td align="center" valign="middle">183</td><td align="center" valign="middle">382</td><td align="center" valign="middle">26</td><td align="right" valign="bottom">207</td><td align="center" valign="middle">176</td><td align="center" valign="middle">282</td><td align="center" valign="middle">20</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.5721</td></tr><tr><td align="center" valign="middle">Tau memb (ms)</td><td align="center" valign="middle">27.0</td><td align="center" valign="middle">22.4</td><td align="center" valign="middle">41.4</td><td align="center" valign="middle">25</td><td align="center" valign="middle">33.0</td><td align="center" valign="middle">28.7</td><td align="center" valign="middle">51.7</td><td align="center" valign="middle">20</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.1407</td></tr><tr><td align="center" rowspan="3" valign="middle">AP properties</td><td align="center" valign="middle">Threshold (mV)</td><td align="center" valign="middle">79.0</td><td align="center" valign="middle">63.2</td><td align="center" valign="middle">85.1</td><td align="center" valign="middle">26</td><td align="center" valign="middle">83.4</td><td align="center" valign="middle">77.3</td><td align="center" valign="middle">88.5</td><td align="center" valign="middle">20</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0988</td></tr><tr><td align="center" valign="middle">Amplitude (mV)</td><td align="center" valign="middle">-45.8</td><td align="center" valign="middle">-51.5</td><td align="center" valign="middle">-42.2</td><td align="center" valign="middle">26</td><td align="center" valign="middle">-42.9</td><td align="center" valign="middle">-44.6</td><td align="center" valign="middle">-42.0</td><td align="center" valign="middle">20</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0727</td></tr><tr><td align="center" valign="middle">Width (ms)</td><td align="center" valign="middle">1.2</td><td align="center" valign="middle">0.9</td><td align="center" valign="middle">1.6</td><td align="center" valign="middle">26</td><td align="center" valign="middle">1.2</td><td align="center" valign="middle">0.9</td><td align="center" valign="middle">1.5</td><td align="center" valign="middle">20</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.8680</td></tr></tbody></table><table-wrap-foot><fn><p>Median: quantile 50; Q1: quantile 25; Q3: quantile 75; n: number of cells; Vrest: Resting membrane potential ; Ri : input resistance.</p></fn></table-wrap-foot></table-wrap><p>Increased MC-PN GABAergic transmission synaptic transmission in Ts mice can be attributed to axonal sprouting of MCs and/or increased dendritic branching of PNs. We performed a morphometric analysis of both cell types and found that the spatial distribution and total length of axons and dendrites of MCs were similar in both genotypes (<xref ref-type="fig" rid="fig2">Figure 2d–f</xref>). Likewise, both apical and basal dendrite arborizations of PNs were indistinguishable in Eu and Ts mice (<xref ref-type="fig" rid="fig2">Figure 2g–i</xref>).</p><p>These experiments and those illustrated in <xref ref-type="fig" rid="fig1">Figure 1</xref> indicate that the increased dendritic inhibitory loop involving MCs and PNs can be largely attributable to alteration of synaptic transmission between these two cell types.</p></sec><sec id="s2-3"><title>Excitability of PV cells, and not their perisomatic control of PNs, is strongly altered in Ts mice</title><p>Is the synaptic enhancement of the dendritic inhibitory loop involving MCs a specific alteration or a general feature of glutamatergic and GABAergic synapses in Ts mice? To address this question, we measured glutamatergic recruitment onto, and synaptic inhibition from, another prominent interneuron class, the PV basket cell. This interneuron class is characterized by its ability to fire high frequency, non-adapting trains of fast action potentials. These properties, along with perisomatic synaptic targeting of PNs, make the PV cell an efficient regulator of PN output. We thus crossed Ts65Dn with PValb-tdTomato mice, a line that expresses TdTomato specifically in PV-positive interneurons (<xref ref-type="bibr" rid="bib31">Kaiser et al., 2016</xref>). We recorded uIPSCs and uEPSCs (<xref ref-type="fig" rid="fig3">Figure 3a–d</xref>) from pairs of synaptically connected PNs and PV cells. The amplitude, failure rate and charge transfer of uIPSC trains evoked by action potentials in presynaptic PV interneurons were similar in both genotypes (<xref ref-type="fig" rid="fig3">Figure 3a,b</xref>; <xref ref-type="table" rid="table7">Table 7</xref>). Likewise, the amplitudes, failure rates and charge transfer of uEPSCs elicited by PN firing were indistinguishable in Eu and Ts mice (<xref ref-type="fig" rid="fig3">Figure 3c,d</xref>; <xref ref-type="table" rid="table8">Table 8</xref>). Consistently, no difference was observed in short-term plasticity of both uIPSCs and uEPSCs in Ts and Eu mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Perisomatic inhibition by PV-INs is normal in Ts mice.</title><p>(<bold>a</bold>) Left: scheme of the PV-PN perisomatic inhibitory circuit assessed using dual whole-cell patch-clamp recordings. Right: representative voltage-clamp traces corresponding to uIPSCs evoked upon application of 5 action currents (50 Hz) to the presynaptic PV-IN. Eu: individual (gray) and average (black); Ts: individual (light blue) and average (blue) traces are superimposed. (<bold>b</bold>) Population data of uIPSC amplitude (p=0.4901, Mann-Whitney U-test), failure rate of the postsynaptic response evoked by the first action potential of the train (p=0.7185, Mann-Whitney U-test) and total charge transferred during the 5 APs train (Q, p=0.579, Mann-Whitney U-test, n = 26 and 15 pairs for Eu and Ts, respectively). (<bold>c–d</bold>) Same as in a-b, but for glutamatergic uEPSCs triggered in the presynaptic PN and recorded in the postsynaptic PV IN in both genotypes (Amplitude: p=0.233, Mann-Whitney U-test; Failure Rate: p=0.214, Mann-Whitney U-test; Q: p=0. 3711, Mann-Whitney U-test; n = 15 and 9 pairs for Eu and Ts, respectively).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Synaptic properties of the perisomatic inhibitory loop.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58731-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Short term plasticity of the perisomatic inhibitory loop in Ts.</title><p>(<bold>a</bold>) Schematic representation of the inhibitory synapse of the cortical dendritic inhibitory loop mediated by MCs. (<bold>b</bold>) Normalized amplitude of IPSCs evoked by a 5-AP train applied at 50 Hz to the presynaptic MC (Two-Way ANOVA genotype factor: F<sub>(1,32)</sub>=3.127, p=0.0865). (<bold>c</bold>) Failure rate of synaptic responses evoked by each AP of the train (Two-Way ANOVA genotype factor: F<sub>(1,32)</sub>=0.5324, p=0.4709, n = 26 and 8 pairs for Eu and Ts, respectively). (<bold>d</bold>) Schematic representation of the excitatory synapse between PN and MCs. (<bold>e</bold>) Normalized amplitude of EPSCs evoked by a 5-AP train applied at 50 Hz to the presynaptic PN (Two-Way ANOVA genotype factor: F<sub>(1,22)</sub>=2.022, p=0.1755). (<bold>f</bold>) Failure rate of synaptic responses evoked by each AP of the train (Two-Way ANOVA genotype factor: F <sub>(1,22)</sub>=0.7742, p=0.3928, n = 15 and 9 pairs for Eu and Ts, respectively).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Short term plasticity of the perisomatic inhibitory loop in Ts.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58731-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig3-figsupp1-v2.tif"/></fig></fig-group><table-wrap id="table7" position="float"><label>Table 7.</label><caption><title>Direct perisomatic inhibition.</title><p>PV to PN synaptic efficiency evaluation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="8" valign="bottom">Perisomatic inhibition</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="4" valign="middle">Euploid</th><th align="center" colspan="4" style="author-callout-style-b1" valign="middle">Ts65Dn</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="left" valign="middle"/><th align="left" valign="middle"/><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">test</th><th align="center" valign="middle">p value</th></tr></thead><tbody><tr><td align="center" rowspan="3" valign="middle">PV-PN IPSC</td><td align="center" valign="middle">Amplitude (pA)</td><td align="center" valign="middle">188.43</td><td align="center" valign="middle">74.87</td><td align="center" valign="middle">289.03</td><td align="center" valign="middle">26</td><td align="center" valign="middle">144.52</td><td align="center" valign="middle">46.10</td><td align="center" valign="middle">209.78</td><td align="center" valign="middle">15</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.49</td></tr><tr><td align="center" valign="middle">Failure Rate</td><td align="center" valign="middle">0.00</td><td align="center" valign="middle">0.00</td><td align="center" valign="middle">0.03</td><td align="center" valign="middle">26</td><td align="center" valign="middle">0.00</td><td align="center" valign="middle">0.00</td><td align="center" valign="middle">0.00</td><td align="center" valign="middle">15</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.7185</td></tr><tr><td align="center" valign="middle">Charge (pC)</td><td align="center" valign="middle">2.88</td><td align="center" valign="middle">1.92</td><td align="center" valign="middle">5.02</td><td align="center" valign="middle">26</td><td align="center" valign="middle">4.89</td><td align="center" valign="middle">1.89</td><td align="center" valign="middle">5.85</td><td align="center" valign="middle">15</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.579</td></tr></tbody></table><table-wrap-foot><fn><p>PV to PN synaptic efficiency evaluation. Median: quantile 50; Q1: quantile 25; Q3: quantile 75; n: number of cells; IPSC: Inhibitory postsynaptic current.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table8" position="float"><label>Table 8.</label><caption><title>Recruitment of PV-INs by PNs.</title><p>PN to PV synaptic efficiency evaluation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="8" valign="bottom">Perisomatic inhibition</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="4" valign="middle">Euploid</th><th align="center" colspan="4" style="author-callout-style-b1" valign="middle">Ts65Dn</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="left" valign="middle"/><th align="left" valign="middle"/><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">test</th><th align="center" valign="middle">p value</th></tr></thead><tbody><tr><td align="center" rowspan="3" valign="middle">PN-PVEPSC</td><td align="center" valign="middle">Amplitude (pA)</td><td align="center" valign="middle">65.66</td><td align="center" valign="middle">19.28</td><td align="center" valign="middle">124.50</td><td align="center" valign="middle">15</td><td align="center" valign="middle">20.41</td><td align="center" valign="middle">14.10</td><td align="center" valign="middle">84.25</td><td align="center" valign="middle">9</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.23304</td></tr><tr><td align="center" valign="middle">Failure Rate</td><td align="center" valign="middle">0.00</td><td align="center" valign="middle">0.00</td><td align="center" valign="middle">0.27</td><td align="center" valign="middle">15</td><td align="center" valign="middle">0.13</td><td align="center" valign="middle">0.00</td><td align="center" valign="middle">0.57</td><td align="center" valign="middle">9</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.21402</td></tr><tr><td align="center" valign="middle">Charge (pC)</td><td align="center" valign="middle">0.62</td><td align="center" valign="middle">0.29</td><td align="center" valign="middle">0.90</td><td align="center" valign="middle">15</td><td align="center" valign="middle">0.42</td><td align="center" valign="middle">0.20</td><td align="center" valign="middle">0.55</td><td align="center" valign="middle">9</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.3711</td></tr></tbody></table><table-wrap-foot><fn><p>Median: quantile 50; Q1: quantile 25; Q3: quantile 75; n: number of cells; EPSC: Excitatory postsynaptic current.</p></fn></table-wrap-foot></table-wrap><p>Surprisingly, however, we found that intrinsic excitability of PV cells of Ts mice was strongly altered. These interneurons required one fourth less current (rheobase) necessary to induce firing action potentials. Accordingly, the gain of the f-I curves of Ts mice was dramatically reduced, as compared to their Eu littermates (<xref ref-type="fig" rid="fig4">Figure 4a–c</xref>; <xref ref-type="table" rid="table9">Table 9</xref>). Moreover, PV cells in Ts mice could not sustain high-frequency firing in response to 2 s-long depolarization, and the maximal spike rate was near half of that reached by PV cells in Eu mice (<xref ref-type="fig" rid="fig4">Figure 4a–c</xref>; <xref ref-type="table" rid="table9">Table 9</xref>). Notably, in Ts mice, action potential width was 1.7-fold wider and input resistance was 1.9-fold larger than that observed in Eu mice (<xref ref-type="fig" rid="fig4">Figure 4d,e</xref>,). Conversely, action potential threshold and amplitude were not affected (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>; <xref ref-type="table" rid="table10">Table 10</xref>). Abnormal passive and active properties of PV cells of Ts mice were present throughout all ages under study. Importantly, in Eu mice, PV-cell active and passive properties reached values similar to those reported for this cell type (<xref ref-type="bibr" rid="bib31">Kaiser et al., 2016</xref>; <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). Similarly to SST cells, the density of PV-INs in mPFC was similar in the two genotypes (<xref ref-type="fig" rid="fig4">Figure 4f</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Altered excitability of PV cells in Ts mice.</title><p>(<bold>a</bold>) Representative voltage traces in response to current steps of increased amplitudes applied to to PV-INs from Eu (gray) and Ts (blue). (<bold>b</bold>) Representative F-I curves recorded from Eu (top) and Ts (bottom) individual interneurons. Continuous lines represent logarithmic fit used to estimate Rheobase and Gain in each recorded cell. (<bold>c</bold>) Left: Rheobase population data for Eu (194.9 ± 22.4 pA) and Ts mice (85.0 ± 15.3 pA; p=0.00038, Mann-Whitney U-test). Middle: Gain population data for Eu (150.8 ± 22.6 Hz) and Ts mice (47.2 ± 9.4 Hz; p=0.00035, Mann-Whitney U-test). Right: Maximal spiking rate reached upon current injection (p=0.04, Mann-Whitney U-test, n = 28 and 26 cells for Eu and Ts, respectively). (<bold>d</bold>) Left: representative action-potential traces, scaled to the peak, from Eu (black) and Ts (blue) mice. Right: population data of AP width in the two genotypes. (<bold>e</bold>) Population data of input resistance measured in Eu and Ts PV-INs. (<bold>f</bold>) Quantification of PV-INs somas in the mPFC of Eu and Ts mice. Left: Epifluorescence images of immunolabeled PV cells in coronal slices from Ts::PV mice. Right: density of PV cells Eu and Ts (n = 6 and 7 mice for Eu and Ts, respectively; p=0.2602, Mann-Whitney test). *: p&lt;0.05; **: p&lt;0.01.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Excitability of PV cells.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58731-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Specific alteration of mPFC PV-INs electrical properties in Ts65Dn mice.</title><p>(<bold>a</bold>) AP thresholds estimated as the voltage at which the derivative of Vm as function of time (dV/dt) reaches the limit of 10 mV/ms. Eu: −43 mV −47-−39 (n = 26 cells), Ts: −44 mV −46-−41 (n = 26 cells; p=0.0988 Student’s T test). (<bold>b</bold>) AP amplitude measured as the difference between Vm at threshold and Vm at peak Eu: 79, 63–85 mV (n = 26 cells), Ts: 69, 63–73 mV (n = 26, p=0.8680, Mann-Whitney U-test). (<bold>c</bold>) Resting membrane potential. Eu: −71,–75-−69 (n = 26 cells), Ts: −69,–71-−66 (n = 26 cells, p=0.0566, Student’s T test). (<bold>d</bold>) Decay tau of the membrane Eu: 12, 7–21 ms (n = 26 cells), Ts: 26, 20–37 ms (n = 25 cells, p=0.14067, Mann-Whitney U-test). Boxplots: represent median, percentiles 25 and 75 and whiskers are percentiles 5 and 95. Individual points represent average values from each recorded synaptic connection.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Singleaction potentialand passive properties of mPFC PV cells.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58731-fig4-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>PV cells passive and active properties as function of Age.</title><p>Passive properties plotted as a function of age during the developmental period under study. (<bold>a</bold>) Resting membrane potential (Vrest). (<bold>b</bold>) Input Resistance (R<sub>i</sub>). (<bold>c</bold>) Membrane time constant (Tau membrane). (<bold>d</bold>) Action potential threshold. (<bold>e</bold>) Action potential amplitude. (<bold>f</bold>) Action potential half width (n = 28 and 26 cells for Eu and Ts, respectively). In all panels continuous lines represent the linear fit to each data set (Eu: gray, Ts: blue). Spearman correlation test p value is indicated in all panels for Eu (gray) and Ts (blue).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig4-figsupp2-v2.tif"/></fig></fig-group><table-wrap id="table9" position="float"><label>Table 9.</label><caption><title>PV-INs excitability.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="4" valign="middle">Euploid</th><th align="center" colspan="4" style="author-callout-style-b1" valign="middle">Ts65Dn</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="left" valign="bottom"/><th align="left" valign="middle"/><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">test</th><th align="center" valign="middle">p value</th></tr></thead><tbody><tr><td align="center" rowspan="3" valign="middle">Excitability</td><td align="center" valign="middle">Rheobase (pA)</td><td align="center" valign="middle">198.7</td><td align="center" valign="middle">104.1</td><td align="center" valign="middle">276.7</td><td align="center" valign="middle">19</td><td align="center" valign="middle">54.4</td><td align="center" valign="middle">34.6</td><td align="center" valign="middle">98.7</td><td align="center" valign="middle">26</td><td align="center" valign="middle">MW</td><td align="center" valign="middle">0.0004</td></tr><tr><td align="center" valign="middle">Gain (Hz)</td><td align="center" valign="middle">163.2</td><td align="center" valign="middle">34.6</td><td align="center" valign="middle">233.8</td><td align="center" valign="middle">19</td><td align="center" valign="middle">28.2</td><td align="center" valign="middle">20.2</td><td align="center" valign="middle">44.2</td><td align="center" valign="middle">26</td><td align="center" valign="middle">MW</td><td align="center" valign="middle">0.0004</td></tr><tr><td align="center" valign="middle">Max Spiking Rate (Hz)</td><td align="center" valign="middle">99.5</td><td align="center" valign="middle">45.2</td><td align="center" valign="middle">142.3</td><td align="center" valign="middle">19</td><td align="center" valign="middle">47.9</td><td align="center" valign="middle">45.3</td><td align="center" valign="middle">63.3</td><td align="center" valign="middle">26</td><td align="center" valign="middle">MW</td><td align="center" valign="middle">0.0001</td></tr></tbody></table><table-wrap-foot><fn><p>Median: quantile 50; Q1: quantile 25; Q3: quantile 75; n: number of cells; InjCurr50: amount of current injected to reach 50% of the maximal spiking rate.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table10" position="float"><label>Table 10.</label><caption><title>PV-INs passive and action potential (AP) properties.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="4" valign="middle">Euploid</th><th align="center" colspan="4" style="author-callout-style-b1" valign="middle">Ts65Dn</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="left" valign="middle"/><th align="left" valign="middle"/><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">n</th><th align="center" valign="middle">test</th><th align="center" valign="middle">p value</th></tr></thead><tbody><tr><td align="center" rowspan="3" valign="middle">Passive properties</td><td align="center" valign="middle">Vrest (mV)</td><td align="center" valign="middle">-71</td><td align="center" valign="middle">-75</td><td align="center" valign="middle">-69</td><td align="center" valign="middle">28</td><td align="center" valign="middle">-70</td><td align="center" valign="middle">-71</td><td align="center" valign="middle">-66</td><td align="center" valign="middle">26</td><td align="center" valign="middle">T-test</td><td align="center" valign="middle">0.1808</td></tr><tr><td align="center" valign="middle">Ri (MΩ)</td><td align="center" valign="middle">154</td><td align="center" valign="middle">93</td><td align="center" valign="middle">271</td><td align="center" valign="middle">28</td><td align="center" valign="middle">406</td><td align="center" valign="middle">264</td><td align="center" valign="middle">581</td><td align="center" valign="middle">26</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0001</td></tr><tr><td align="center" valign="middle">Tau memb (ms)</td><td align="center" valign="middle">12.0</td><td align="center" valign="middle">6.5</td><td align="center" valign="middle">20.6</td><td align="center" valign="middle">28</td><td align="center" valign="middle">25.8</td><td align="center" valign="middle">20.2</td><td align="center" valign="middle">37.3</td><td align="center" valign="middle">25</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0003</td></tr><tr><td align="center" rowspan="3" valign="middle">AP properties</td><td align="center" valign="middle">Threshold (mV)</td><td align="center" valign="middle">-43.4</td><td align="center" valign="middle">-47.0</td><td align="center" valign="middle">-39.5</td><td align="center" valign="middle">26</td><td align="center" valign="middle">-44.0</td><td align="center" valign="middle">-46.0</td><td align="center" valign="middle">-41.3</td><td align="center" valign="middle">26</td><td align="center" valign="middle">T-test</td><td align="center" valign="middle">0.7891</td></tr><tr><td align="center" valign="middle">Amplitude (mV)</td><td align="center" valign="middle">65.2</td><td align="center" valign="middle">54.6</td><td align="center" valign="middle">70.3</td><td align="center" valign="middle">25</td><td align="center" valign="middle">69.0</td><td align="center" valign="middle">62.8</td><td align="center" valign="middle">73.4</td><td align="center" valign="middle">25</td><td align="center" valign="middle">T-test</td><td align="center" valign="middle">0.1019</td></tr><tr><td align="center" valign="middle">Width (ms)</td><td align="center" valign="middle">0.8</td><td align="center" valign="middle">0.7</td><td align="center" valign="middle">1.3</td><td align="center" valign="middle">26</td><td align="center" valign="middle">1.3</td><td align="center" valign="middle">1.0</td><td align="center" valign="middle">1.6</td><td align="center" valign="middle">26</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0012</td></tr></tbody></table><table-wrap-foot><fn><p>Median: quantile 50; Q1: quantile 25; Q3: quantile 75; n: number of cells; Vrest: Resting membrane potential; Ri : input resistance.</p></fn></table-wrap-foot></table-wrap><p>Altogether, these results indicate that, contrary to dendritic inhibition, the synaptic efficiency of the perisomatic feedback loop mediated by PV-INs was normal in Ts mice. Yet, PV-INs of Ts mice lost their characteristic electrophysiological fast-spiking signature, and their excitability was dramatically increased.</p></sec><sec id="s2-4"><title>Reduced spiking activity in vivo and increased tuning with network oscillations in Ts65Dn mPFC</title><p>Increased dendritic inhibition by the MC-PN loop, altered spiking activity of PV cells and their increased excitability will likely strongly influence the spiking properties and dynamics of mPFC PNs in vivo during spontaneous network activity. In order to assess the activity of the mPFC in vivo, we performed simultaneous local field potential (LFP) and loose-patch, juxtacellular recordings from layer 2/3 putative PNs to monitor their spiking dynamics related to overall network activity (<xref ref-type="fig" rid="fig5">Figure 5a</xref>). In vivo recordings exhibited typical oscillatory activity consisting of UP and DOWN states (<xref ref-type="bibr" rid="bib47">Ruiz-Mejias et al., 2011</xref>). UP and DOWN states were similar in frequency and duration in Ts mice and their Eu littermates (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). UP states were enriched in γ-band activity (30–100 Hz) and exhibited increased probability of spiking activity (<xref ref-type="bibr" rid="bib47">Ruiz-Mejias et al., 2011</xref>; <xref ref-type="fig" rid="fig5">Figure 5a</xref>). Juxtacellular recordings from individual mPFC putative PNs revealed a near 50% decrease in the overall spiking rate in Ts mice as compared to their Eu littermates (<xref ref-type="fig" rid="fig5">Figure 5b</xref>, <xref ref-type="table" rid="table11">Table 11</xref>). This difference was explained by a significant reduction of spiking rate during UP but not DOWN states (data not shown). Analysis of LFP power spectral density (PSD) did not show a significant difference in the two genotypes (<xref ref-type="fig" rid="fig5">Figure 5c</xref>). Interestingly, however, when we analyzed LFP waveform specifically during periods of neuronal spiking activity (spike-triggered LFP or stLFP), we found that, in both genotypes, average stLFPs exhibited marked voltage deflections, indicating that spike probability was not randomly distributed but locked to LFP oscillations (<xref ref-type="fig" rid="fig5">Figure 5d</xref>). The peak-to-peak amplitude of the stLFP was much larger in Ts than in Eu mice (<xref ref-type="fig" rid="fig5">Figure 5d,e</xref>, <xref ref-type="table" rid="table11">Table 11</xref>), and, remarkably, the spectral power of the stLFP was largely increased in Ts mice, selectively in the β-γ-frequency band (<xref ref-type="fig" rid="fig5">Figure 5f</xref>). In order to quantitatively assess whether PN spikes were differently locked to the phase of network oscillations, we measured the pairwise phase consistency (PPC), which is an unbiased parameter to determine the degree of tuning of single-neuron firing to network rhythmic activity of specific frequencies (<xref ref-type="bibr" rid="bib45">Perrenoud et al., 2016</xref>; <xref ref-type="bibr" rid="bib56">Veit et al., 2017</xref>; <xref ref-type="bibr" rid="bib57">Vinck et al., 2010</xref>). Ts mice exhibited significantly higher PPC values than Eu littermates for frequency bands ranging between 10 and 60 Hz (<xref ref-type="fig" rid="fig4">Figure 4g</xref>, <xref ref-type="table" rid="table12">Table 12</xref>), thus revealing stronger phase locking selectively with β- and low γ-oscillations.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Reduced spiking activity in vivo and increased tuning with network oscillations in anesthetized Ts65Dn mPFC.</title><p>(<bold>a</bold>) Left: scheme depicting simultaneous local field potential (LFP) and juxtacellular recordings in layer 2/3 of the mPFC. Right: representative juxtacellular (top trace), LFP (middle trace) and spectrogram (bottom) recorded in Eu (black traces) and Ts (blue traces) mice. (<bold>b</bold>) Average spiking rate from individual cells. Population data (n = 28 cells, 5 mice and 23 cells, six mice for Eu and Ts, respectively; p=0.03, Mann-Whitney U-test). (<bold>c</bold>) Normalized Power Spectral Density (PSD) from Eu and Ts mice. Shaded green areas correspond to β-γ-frequency ranges. (<bold>d</bold>) Representative portions of averaged LFP around aligned spike (spike-triggered LFP or stLFP). Top: Average traces of aligned spikes from a putative layer 2/3 PN recorded in a Eu (black) and Ts (blue) mouse. Bottom: average of the corresponding stLFPs. Light line: raw averaged trace, thick dark line: low pass filtered trace (cutoff: 100 Hz). (<bold>e</bold>) Average plots of stLFP peak-to-peak amplitude in Eu and Ts mice. (<bold>f</bold>) Normalized Power spectral density of stLFPs. Shaded green areas correspond to β-γ-frequency ranges. (<bold>g</bold>) Pairwise Phase Consistency (PPC) calculated for specific frequency bands (4–10 Hz: p=0.427, 10–20 Hz: p=0.02145, 20–40 Hz: p=0.0418, 40–60 Hz: p=0.01638, 60–80 Hz: p=0.2308, 80–100 Hz: p=0.3161, Mann-Whitney U-test). e-g,: n = 23 cells, 5 mice and 11 cells, six mice for Eu and Ts, respectively. Boxplots represent median, percentiles 25 and 75 and whiskers are percentiles 5 and 95. *: p&lt;0.05; **: p&lt;0.01.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>In vivo spiking activity and phase locking.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58731-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Characterization of slow wave oscillatory activity of LFP in anesthetized Eu and Ts mice.</title><p>(<bold>a</bold>) Representative LFP traces of anesthetized Eu (black, top) and Ts (bottom, blue) mice. (<bold>b</bold>) Histograms of UP states duration from the examples shown in (<bold>a</bold>) Eu (gray bars) and Ts (blue bars) examples. (<bold>c</bold>) Average frequency, population data (left panel; Eu: 1.32 ± 0.02 Hz, Ts: 1.33 ± 0.02 Hz; Student’s T test, p=0.86952) and average duration (right panel; Eu: 305.0 ± 3.3 ms, Ts: 310.9 ± 4.1 ms; Student’s T test, p=0.6352) of UP state did not significantly differed between genotypes (n = 6 and 7 mice, respectively).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-fig5-figsupp1-v2.tif"/></fig></fig-group><table-wrap id="table11" position="float"><label>Table 11.</label><caption><title>LFP and single cell spiking recorded in vivo.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="5" valign="middle">Euploid</th><th align="center" colspan="5" style="author-callout-style-b1" valign="middle">Ts65Dn</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="left" valign="bottom"/><th align="left" valign="middle"/><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">N cells</th><th align="center" valign="middle">N mice</th><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">N cells</th><th align="center" valign="middle">N mice</th><th align="center" valign="middle">test</th><th align="center" valign="middle">p value</th></tr></thead><tbody><tr><td align="left" valign="bottom"/><td align="center" valign="middle">Spiking Rate (Hz)</td><td align="center" valign="middle">0.81</td><td align="center" valign="middle">0.56</td><td align="center" valign="middle">1.24</td><td align="center" valign="middle">28</td><td align="center" valign="middle">6</td><td align="center" valign="middle">0.42</td><td align="center" valign="middle">0.22</td><td align="center" valign="middle">0.92</td><td align="center" valign="middle">23</td><td align="center" valign="middle">5</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0348</td></tr><tr><td align="left" valign="bottom"/><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/><td align="center" valign="middle"/></tr><tr><td align="center" valign="middle">stLFP</td><td align="center" valign="middle">peak-to-peak Amp (µV)</td><td align="center" valign="middle">7.3</td><td align="center" valign="middle">6.0</td><td align="center" valign="middle">8.6</td><td align="center" valign="middle">22</td><td align="center" valign="middle">6</td><td align="center" valign="middle">13.3</td><td align="center" valign="middle">12.3</td><td align="center" valign="middle">17.1</td><td align="center" valign="middle">11</td><td align="center" valign="middle">5</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0011</td></tr></tbody></table><table-wrap-foot><fn><p>Median: quantile 50; Q1: quantile 25; Q3: quantile 75; n: number of cells.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table12" position="float"><label>Table 12.</label><caption><title>Pairwise Phase Consistency (PPC) descriptive statistics and hypothesis tests between genotypes for each frequency band analyzed.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="center" colspan="5" valign="middle">Euploid</th><th align="center" colspan="4" style="author-callout-style-b1" valign="middle">Ts65Dn</th><th align="center" valign="middle"/><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr><tr><th align="left" valign="bottom"/><th align="left" valign="middle">Freq. band</th><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">N cells</th><th align="center" valign="middle">N mice</th><th align="center" valign="middle">median</th><th align="center" valign="middle">Q1</th><th align="center" valign="middle">Q3</th><th align="center" valign="middle">N cells</th><th align="center" valign="middle">N mice</th><th align="center" valign="middle">test</th><th align="center" valign="middle">p value</th></tr></thead><tbody><tr><td align="center" rowspan="6" valign="middle">PPC</td><td align="center" valign="middle">4-10 Hz</td><td align="center" valign="middle">0.0085</td><td align="center" valign="middle">0.0053</td><td align="center" valign="middle">0.0242</td><td align="center" valign="middle">22</td><td align="center" valign="middle">6</td><td align="center" valign="middle">0.0106</td><td align="center" valign="middle">0.0064</td><td align="center" valign="middle">0.0164</td><td align="center" valign="middle">11</td><td align="center" valign="middle">5</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.4270</td></tr><tr><td align="center" valign="middle">10-20 Hz</td><td align="center" valign="middle">0.0046</td><td align="center" valign="middle">0.0011</td><td align="center" valign="middle">0.0237</td><td align="center" valign="middle">22</td><td align="center" valign="middle">6</td><td align="center" valign="middle">0.0213</td><td align="center" valign="middle">0.0163</td><td align="center" valign="middle">0.0379</td><td align="center" valign="middle">11</td><td align="center" valign="middle">5</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0215</td></tr><tr><td align="center" valign="middle">20-40 Hz</td><td align="center" valign="middle">0.0024</td><td align="center" valign="middle">-0.0002</td><td align="center" valign="middle">0.0085</td><td align="center" valign="middle">22</td><td align="center" valign="middle">6</td><td align="center" valign="middle">0.0066</td><td align="center" valign="middle">0.0059</td><td align="center" valign="middle">0.0193</td><td align="center" valign="middle">11</td><td align="center" valign="middle">5</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0418</td></tr><tr><td align="center" valign="middle">40-60 Hz</td><td align="center" valign="middle">0.0009</td><td align="center" valign="middle">-0.0009</td><td align="center" valign="middle">0.0025</td><td align="center" valign="middle">22</td><td align="center" valign="middle">6</td><td align="center" valign="middle">0.0052</td><td align="center" valign="middle">0.0019</td><td align="center" valign="middle">0.0079</td><td align="center" valign="middle">11</td><td align="center" valign="middle">5</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.0164</td></tr><tr><td align="center" valign="middle">60-80 Hz</td><td align="center" valign="middle">-0.0003</td><td align="center" valign="middle">-0.0007</td><td align="center" valign="middle">0.0004</td><td align="center" valign="middle">22</td><td align="center" valign="middle">6</td><td align="center" valign="middle">0.0001</td><td align="center" valign="middle">-0.0005</td><td align="center" valign="middle">0.0009</td><td align="center" valign="middle">11</td><td align="center" valign="middle">5</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.2308</td></tr><tr><td align="center" valign="middle">80-100 Hz</td><td align="center" valign="middle">-0.0002</td><td align="center" valign="middle">-0.0009</td><td align="center" valign="middle">0.0013</td><td align="center" valign="middle">22</td><td align="center" valign="middle">6</td><td align="center" valign="middle">-0.0004</td><td align="center" valign="middle">-0.0008</td><td align="center" valign="middle">0.0002</td><td align="center" valign="middle">11</td><td align="center" valign="middle">5</td><td align="center" valign="middle">MW-test</td><td align="center" valign="middle">0.3161</td></tr></tbody></table><table-wrap-foot><fn><p>Median: quantile 50; Q1: quantile 25; Q3: quantile 75; n: number of cells. We considered only cells from which we recorded at least 250 action potentials in order to obtain reliable PPC values.</p></fn></table-wrap-foot></table-wrap><p>Altogether, these results indicate that mPFC PNs in Ts mice fire less than their Eu littermates, but their spontaneous spiking activity is more strongly tuned to β- and γ-frequency bands. Reduced firing rate and increased phase locking with fast oscillations are both consistent with increased activity of inhibitory interneurons (<xref ref-type="bibr" rid="bib10">Cardin et al., 2009</xref>; <xref ref-type="bibr" rid="bib13">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="bib52">Sohal et al., 2009</xref>; <xref ref-type="bibr" rid="bib56">Veit et al., 2017</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we analyzed synaptic and intrinsic properties of two major inhibitory circuits of the prefrontal cortex in a relevant mouse model of DS. We found specific alterations of distinct GABAergic circuits. In particular, we demonstrate that the dendritic inhibitory synaptic loop involving MCs and PNs was strongly potentiated in Ts, as compared to euploid control mice. In contrast, the perisomatic synaptic inhibitory control of PNs by PV cells was not affected in Ts mice. Strikingly, however, the excitability of PV cells was profoundly altered. These GABAergic circuit-specific alterations correlate with reduced PN spiking, and enhanced coupling with network β-γ-activity in Ts mice in vivo.</p><p>We analyzed MCs, which are a subset of SST interneurons, specialized in inhibiting the distal portion of apical dendrites of PNs, by ascending their axons in L1 (<xref ref-type="bibr" rid="bib32">Kawaguchi and Kubota, 1998</xref>), where PN dendrites integrate top-down input originating from distal brain areas. In the hippocampus, dendritic inhibition strongly regulates PN dendrite electrogenesis and supra-linearity (<xref ref-type="bibr" rid="bib38">Lovett-Barron et al., 2012</xref>), likely modulating the emergence of burst firing (<xref ref-type="bibr" rid="bib46">Royer et al., 2012</xref>). Interestingly, α5–mediated dendritic inhibition in the hippocampus, known to strongly control dendritic integration and action potential firing (<xref ref-type="bibr" rid="bib48">Schulz et al., 2018</xref>), is also enhanced in Ts65Dn mice and strongly control NMDAR activation, nonlinear dendritic integration, and AP firing (<xref ref-type="bibr" rid="bib49">Schulz et al., 2019</xref>). In the neocortex, integration of top-down information in L1 and consequent dendrite-dependent generation of burst activity was hypothesized to underlie the encoding of context-rich, salient information (<xref ref-type="bibr" rid="bib36">Larkum, 2013</xref>). Our results indicate a specific synaptic strengthening of the dendritic inhibitory loop involving MCs in Ts mice, suggesting a major impact on PN dendritic integration and electrogenesis.</p><p>Enhanced dendritic inhibition by MCs in DS could underlie the deficits of long-term plasticity of glutamatergic synapses similar to those observed in the hippocampus of Ts mice. Indeed, these LTP deficits can be recovered by treatment of allosteric modulators of α5-GABA<sub>A</sub>Rs (<xref ref-type="bibr" rid="bib20">Duchon et al., 2020</xref>; <xref ref-type="bibr" rid="bib40">Martínez-Cué et al., 2013</xref>; <xref ref-type="bibr" rid="bib49">Schulz et al., 2019</xref>). Likewise, the enhanced MC-PN inhibitory loop in Ts mice shown here can provide a mechanism for the rescue of cognitive deficits in Ts mice, operated by selective pharmacology of α5-GABA<sub>A</sub>Rs (<xref ref-type="bibr" rid="bib8">Braudeau et al., 2011</xref>; <xref ref-type="bibr" rid="bib20">Duchon et al., 2020</xref>; <xref ref-type="bibr" rid="bib40">Martínez-Cué et al., 2013</xref>). This subunit of GABA<sub>A</sub>Rs, whose synaptic vs. extrasynaptic expression is still debated (<xref ref-type="bibr" rid="bib3">Ali and Thomson, 2008</xref>; <xref ref-type="bibr" rid="bib7">Botta et al., 2015</xref>; <xref ref-type="bibr" rid="bib25">Glykys and Mody, 2010</xref>; <xref ref-type="bibr" rid="bib26">Hannan et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Hausrat et al., 2015</xref>; <xref ref-type="bibr" rid="bib48">Schulz et al., 2018</xref>; <xref ref-type="bibr" rid="bib50">Serwanski et al., 2006</xref>), mediate dendritic synaptic inhibition from neocortical MCs (<xref ref-type="bibr" rid="bib3">Ali and Thomson, 2008</xref>) and their hippocampal counterparts (the oriens-lacunosum moleculare or O-LM interneurons, <xref ref-type="bibr" rid="bib48">Schulz et al., 2018</xref>). Here, we confirmed that α5-containing GABA<sub>A</sub>Rs are majorly responsible for MC-PN dendritic synaptic inhibition, due to the overall block of α5IA, which was close to the max potency of this drug (<xref ref-type="bibr" rid="bib17">Dawson et al., 2006</xref>).</p><p>The enhancement of the dendritic inhibitory loop involving MCs and PNs in Ts mice could not be attributed to alterations of axonal and/or dendritic arborizations in the mutant mice. On the other hand, it could be due to a combination of pre- and postsynaptic mechanisms, including alterations of release probability, number of release sites or quantal size at either GABAergic or glutamatergic synapses involved in this circuit. The strong increase of synaptic charge at MC-PN GABAergic synapses could be attributed to alterations of uIPSC waveform in Ts mice. Although the small change of uIPSC rise time can in principle account for, at least in part, an increase in synaptic charge, it is unlikely to account for the 5-fold increase of synaptic charge, with no changes in uIPSC decay.</p><p>The robust increase of synaptic charge in Ts mice is likely due to one or a combination of different non-linearities that dynamically emerge during a spike train. These include the recruitment of peri- or extrasynaptic GABA<sub>A</sub>Rs, possible alterations of release probability or quantal size during trains and differences in postsynaptic dendritic filtering in the two genotypes. These complex interplays between these factors occur at distal dendrites; therefore, they are difficult to tease out from somatic recordings as they are characterized by poor dendritic voltage control due to space-clamping constraints. The enhanced short-term depression of MC-PN uIPSCs that we report here suggests that release probability at dendritic GABAergic synapses from MCs is increased in Ts mice. This is consistent with increased short-term depression of inhibition reported in the dentate gyrus (<xref ref-type="bibr" rid="bib35">Kleschevnikov et al., 2012</xref>), but not with unaltered short-term plasticity shown in CA1 (<xref ref-type="bibr" rid="bib41">Mitra et al., 2012</xref>). These discrepancies could be ascribed to differences between brain regions. Moreover, they could also be a consequence of non-specific recruitment of presynaptic axons by global extracellular stimulation, in contrast to the isolation of unitary synaptic responses by dual intracellular recordings as reported here. The lack of short-term plasticity alterations at PN-MC glutamatergic synapses suggests that increased excitatory recruitment of MCs is due to alterations at postsynaptic sites. Future studies will be necessary to pinpoint the exact biophysical and anatomical alterations underlying the prominent increase of dendritic inhibition operated by MCs in DS.</p><p>Potentiation of glutamatergic synapses in Ts mice seems to be specific for PN-MC connections, as PN-PV synapses were similar in both genotypes, suggesting that presynaptic terminals of local glutamatergic synapses can undergo target-specific modulation of their strength. Intriguingly, it has been recently shown that an increase of the excitatory drive of hippocampal interneurons (due to triplication of GluR5 kainate receptor expression) could explain excess of inhibition received by pyramidal neurons in the Ts2Cje Down syndrome mouse model (<xref ref-type="bibr" rid="bib55">Valbuena et al., 2019</xref>). Therefore, a similar gene overdose of kainate receptors can boost the recruitment of specific interneurons in the PFC of Ts mice.</p><p>The strong increase of membrane resistance of PV cells in Ts mice underlies the augmented intrinsic excitability and can produce early ectopic bouts of activity, thus contributing to network over-inhibition. Enhanced membrane resistance could result from alterations in the expression of TWIK1 and TASK1 leak channels. Indeed, these channels underlie the developmental decrease of membrane resistance in PV cells (<xref ref-type="bibr" rid="bib42">Okaty et al., 2009</xref>). In contrast, the inability of PV cells of Ts mice to sustain high frequency firing could prevent these interneurons from generating high-frequency bursts of action potentials and therefore have a detrimental effect on the temporal coding of these interneurons.</p><p>Interestingly, however, despite the dramatic alterations of intrinsic excitability in Ts PV cells, their output synaptic perisomatic inhibition was similar in both genotypes. This, despite the widening of single PV-cell action potentials, which could, in principle change the presynaptic Ca<sup>2+</sup> dynamics and thus alter release probability. Since action potentials are recorded in the soma, the lack of effect at PV-cell synapses could be due to soma-specific alterations. Alternatively, since neocortical PV-PN GABAergic synapses exhibit high release probability (<xref ref-type="bibr" rid="bib18">Deleuze et al., 2019</xref>; <xref ref-type="bibr" rid="bib32">Kawaguchi and Kubota, 1998</xref>), alterations of spike width might not be enough to produce additional increases. Increase of action potential width in Ts mice could be due to changes in the expression Kv3.1b potassium channels, known to underlie the fast repolarization of action potentials and fast-spiking behavior of PV cells (<xref ref-type="bibr" rid="bib21">Erisir et al., 1999</xref>). Future experiments will be necessary to reveal the exact molecular mechanism underlying the altered firing properties of PV cells, which, in Ts mice, have lost their characteristic fast-spiking signature.</p><p>The aberrant active and passive properties of PV cells in Ts mice could be due to a delayed development of these interneurons. Indeed, during development, neocortical PV cells display marked accelerations of single action potentials and increased firing frequency, accompanied by decreased input resistance (<xref ref-type="bibr" rid="bib42">Okaty et al., 2009</xref>). Although we cannot rule out the possibility of a delayed development of PV cells in Ts mice, these interneurons showed abnormal passive and active properties within the entire age range studied here. It will be interesting to determine whether these profound alterations of PV-cell firing are present with the same incidence and magnitude along the entire life span of Ts mice. Although previous reports have shown higher number of inhibitory interneurons in the hippocampus (<xref ref-type="bibr" rid="bib30">Hernández-González et al., 2015</xref>) and somatosensory cortex (<xref ref-type="bibr" rid="bib6">Aziz et al., 2018</xref>; <xref ref-type="bibr" rid="bib11">Chakrabarti et al., 2010</xref>) we failed to detect significant differences in the density of both SST- and PV-positive interneurons in the mPFC. This could be due to differences between brain regions. A systematic comparative analysis will be required to better understand the consequences of DS neurodevelopmental alterations of the cellular composition in different brain regions.</p><p>Both potentiation of the dendritic inhibitory loop and increased PV-cell excitability are consistent with the alterations of PN spiking activity that we recorded in vivo. Indeed, reduced spike rates and increased tuning in the β-γ-frequency range are both consistent with increased activity of inhibitory neurons (<xref ref-type="bibr" rid="bib5">Atallah et al., 2012</xref>; <xref ref-type="bibr" rid="bib10">Cardin et al., 2009</xref>; <xref ref-type="bibr" rid="bib13">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="bib52">Sohal et al., 2009</xref>; <xref ref-type="bibr" rid="bib56">Veit et al., 2017</xref>). The overall LFP power spectra observed in mPFC is similar in both Ts and Eu mice, consistently with a recent report (<xref ref-type="bibr" rid="bib12">Chang et al., 2020</xref>). However, close examination of stLFP revealed a strong increase in the power of β- and low γ-frequency bands during periods of spiking activity. This likely reflects the consequences of alterations at the level of local microcircuits.</p><p>We cannot directly link the inhibitory circuit-specific alterations that we detected in slices with the increased synchronization of β-γ-activity that we measured in vivo. However, a large body of literature indicates that oscillations in this frequency range strongly depends on the activity of PV cells (<xref ref-type="bibr" rid="bib9">Buzsáki and Wang, 2012</xref>; <xref ref-type="bibr" rid="bib52">Sohal et al., 2009</xref>; <xref ref-type="bibr" rid="bib10">Cardin et al., 2009</xref>). More recently, also SST interneurons were shown to control PN phase coupling with low frequency (30 Hz) neocortical γ-oscillations (<xref ref-type="bibr" rid="bib13">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Veit et al., 2017</xref>). It is therefore tempting to speculate that increased dendritic inhibition from SST-expressing MCs modulates phase coupling of PNs with β- and low γ-oscillations. On the other hand, the increased phase coupling of PN spikes with high-frequency γ-activity could result from the augmented excitability of PV cells. The differential phase coupling of these two interneuron types at distinct frequencies is consistent with the peculiar fast and slower recruitment and biophysical properties of PV interneurons and MCs, respectively. Future experiments involving chemogenetic alterations of PV-interneuron excitability and/or pharmacological manipulations of MC-PN synapses in Ts mice will help decipher the role played by each inhibitory cell subtype in controlling the temporal dynamics of PN firing during different rhythmic cortical network activities. Alternatively, our results could be interpreted as differences in long-range functional connectivity in the two genotypes, possibly due to alterations in myelination and conduction velocity in Ts vs. Eu mice (<xref ref-type="bibr" rid="bib43">Olmos-Serrano et al., 2016a</xref>). Nevertheless, a reduction of axonal conduction velocity would produce a temporal shift in spike-to-phase association, rather than increased phase locking.</p><p>The increase in β-γ-band power and enhanced neural synchronization in these frequency ranges in Ts mice is consistent with recent evidence indicating augmented hippocampal-PFC synchronization and LFP γ-band power during natural non-REM sleep in Ts65Dn mice (<xref ref-type="bibr" rid="bib2">Alemany-González et al., 2020</xref>). This suggests that the alterations of γ-oscillations observed here could play a role in the pathophysiology of sleep disruptions reported in DS children (<xref ref-type="bibr" rid="bib23">Fernandez et al., 2017</xref>) and adults (<xref ref-type="bibr" rid="bib24">Giménez et al., 2018</xref>).</p><p>In sum, here we report direct evidence for over-inhibition of mPFC circuits in a mouse model of DS. However, over-inhibition was not due to a generic increase of GABAergic signaling, but emerged from highly specific synaptic and intrinsic alterations of dendritic and somatic inhibitory circuits, respectively. Future experiments are necessary to reveal whether other inhibitory neuron types are also affected in DS. Likewise, it will be fundamental to assess whether specific dysfunctions of individual GABAergic circuits underlie different aspects of cognitive deficits (e.g. impaired memory and flexibility, autistic traits), which affect individuals with DS.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>C57BL/6-Tg(Pvalb-tdTomato)15Gfng/J (PValb-Tomato)</td><td>Jackson Laboratory</td><td>Stock #: 27395 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:5629295">MGI:5629295</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>Tg(Gad1-EGFP)98Agmo/J, GAD67-GFP (X98)</td><td>Jackson Laboratory</td><td>Stock #: 6340 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3715263">MGI:3715263</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>B6EiC3Sn.BLiA-Ts(1716)65Dn/DnJ (Ts65Dn)</td><td>Jackson Laboratory</td><td>Stock #: 005252 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:2178111">MGI:2178111</ext-link></td><td/></tr></tbody></table></table-wrap><p>Experimental procedures followed national and European (2010/63/EU) guidelines, and have been approved by the authors' institutional review boards and national authorities. All efforts were made to minimize suffering and reduce the number of animals. Experiments were performed on &gt;4 week old and 18- to 25-day-old mice for in vivo and ex vivo recordings, respectively. We used <italic>B6EiC3Sn a/A-Ts(17 <sup>16</sup>)65Dn/J</italic> (also known as Ts65Dn) mice (The Jackson Laboratory, Bar Harbor, Maine; stock #: 001924). For ex vivo slice experiments to label SST-positive MCs, Ts65Dn mice were crossed with <italic>Tg(Gad1-EGFP)98Agmo/J</italic>, also known as GAD67-GFP X98 or GFP-X98 (Jackson Laboratory). To label PV-INs, Ts65Dn mice were crossed with <italic>C57BL/6-Tg(Pvalb-tdTomato)15Gfng/J</italic> (<italic>Pvalb-tdTomato</italic>, Jackson Laboratory). Mice used in this study were of both sexes.</p><sec id="s4-1"><title>In vivo LFP and juxtacellular recordings</title><p>Ts or Eu mice were anesthetized with 15% urethane (1.5 g/kg in physiological solution) and placed on a stereotaxic apparatus. The body temperature was constantly monitored and kept at 37°C with a heating blanket. To ensure a deep and constant level of anesthesia, vibrissae movement, eyelid reﬂex, response to tail, and toe pinching were visually controlled before and during the surgery. A local lidocaine injection was performed over the cranial area of interest and, after a few minutes, a longitudinal incision was performed to expose the skull. Two small cranial windows (&lt;1 mm diameter) were opened at at 2.5 mm from bregma and ±0.5 mm lateral to sagittal sinus (corresponding to the frontal lobe) carefully avoiding any damage to the main vessels while keeping the surface of the brain moist with the normal HEPES-buffered artificial cerebrospinal fluid. Pipettes used to record LFP had 1–2 MΩ resistance while those used for juxtacellular patch-clamp recordings typically had 5–7 MΩ resistance. LFP and patch electrodes were pulled from borosilicate glass capillaries. Signals were amplified with a Multiclamp 700B patch-clamp amplifier (Molecular Devices), sampled at 20 KHz and filtered online at 10 KHz. Signals were digitized with a Digidata 1440A and acquired, using the pClamp 10 software package (Molecular Devices).</p></sec><sec id="s4-2"><title>Preparation of acute slices for electrophysiology</title><p>In order to record intrinsic and synaptic properties of L2/3 neurons of mPFC, we prepared acute cortical slices from the described mouse lines. For these experiments, we used slices cut in the coronal plane (300–350 μm thick). Animals were deeply anesthetized with saturating isofluorane (Vetflurane, Virbac) and immediately decapitated. The brain was then quickly removed and immersed in the cutting choline-based solution, containing the following (in mM): 126 choline chloride, 16 glucose, 26 NaHCO<sub>3</sub>, 2.5 KCl, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 7 MgSO<sub>4</sub>, 0.5 CaCl<sub>2</sub>, cooled to 4°C and equilibrated with a 95–5% O<sub>2</sub>-CO<sub>2</sub> gas mixture. Slices were cut with a vibratome (Leica VT1200S) in cutting solution and then incubated in oxygenated artificial cerebrospinal fluid (aCSF) composed of (in mM): 126 NaCl, 20 glucose, 26 NaHCO<sub>3</sub>, 2.5 KCl, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 1 MgSO<sub>4</sub>, 2 CaCl<sub>2</sub> (pH 7.35, 310-320mOsm/L), initially at 34°C for 30 min, and subsequently at room temperature, before being transferred to the recording chamber where recordings were obtained at 30–32°C.</p></sec><sec id="s4-3"><title>Slice electrophysiology</title><p>Whole-cell patch-clamp recordings were performed in L2/3 of the medial prefrontal cortex (mPFC) neurons. Inhibitory PV-expressing interneurons, labeled with TdTomato in Ts65Dn mice crossed with <italic>Pvalb-tdTomato</italic> mice and Martinotti cells, labeled with GFP in Ts65Dn crossed with GFP-X98 mice, were identified using LED illumination (OptoLED, Cairn Research, Faversham, UK). Excitatory pyramidal neurons (PNs) were visually identified using infrared video microscopy, as cells lacking expression of fluorescent proteins and with somatas exhibiting the classical pyramidal shape. Accordingly, when depolarized with DC current pulses PNs exhibited a typical firing pattern of regular-spiking cells. We used different intracellular solutions depending on the type of experiment and the nature of the responses we wanted to assess. To study passive properties, intrinsic excitability, AP waveform and glutamatergic spontaneous transmission, electrodes were filled with an intracellular solution containing (in mM): 127 K-gluconate, 6 KCl, 10 Hepes, 1 EGTA, 2 MgCl2, 4 Mg-ATP, 0.3 Na-GTP; pH adjusted to 7.3 with KOH; 290–300 mOsm. The estimated reversal potential for chloride (E<sub>Cl</sub>) was approximately −69 mV based on the Nernst equation. To measure GABAergic currents elicited by perisomatic-targeting interneurons, PNs were patched using an intracellular solution containing (in mM): 65 K-gluconate, 70 KCl, 10 Hepes, 1 EGTA, 2 MgCl2, 4 Mg-ATP, 0.3 Na-GTP; pH adjusted to 7.3 with KOH; 290–300 mOsm (the estimated ECl was approximately −16 mV based on the Nernst equation). For distal dendritic uIPSCs, we used a cesium-based solution containing (in mM): 145 CsCl, 10 Hepes, 1 EGTA, 0.1 CaCl2, 2 MgCl2, 4.6 Mg-ATP, 0.4 Na-GTP, 5 QX314-Cl; pH adjusted to 7.3 with CsOH; 290–300 mOsm. Under these recording conditions, activation of GABA<sub>A</sub> receptors resulted in inward currents at a holding potential (Vh) of −70 mV. Voltage values were not corrected for liquid junction potential. Patch electrodes were pulled from borosilicate glass capillaries and had a typical tip resistance of 2–3 MΩ. Signals were amplified with a Multiclamp 700B patch-clamp amplifier (Molecular Devices), sampled at 20–50 KHz and filtered at 4 KHz (for voltage-clamp experiments) and 10 KHz (for current-clamp experiments). Signals were digitized with a Digidata 1440A and acquired, using the pClamp 10 software package (Molecular Devices).</p><p><italic>For paired recordings</italic>, unitary synaptic responses were elicited in voltage-clamp mode by brief somatic depolarizing steps (−70 to 0 mV, 1–2 ms) evoking action currents in presynaptic cells. Neurons were held at −70 mV and a train of 5 presynaptic spikes at 50 Hz was applied.</p></sec><sec id="s4-4"><title>α5IA</title><p>3-(5-methylisoxazol-3-yl)−6-[(1-methyl-1,2,3-triazol-4-yl)methyloxy]−1, 2, 4-triazolo[3, 4-a]phthalazine also named L-822179, IUPAR/BPS 4095 or PubChem CID 6918451 was synthesized by Orga-Link SARL (Magny-les-Hameaux, France), according to <xref ref-type="bibr" rid="bib53">Sternfeld et al., 2004</xref> as in <xref ref-type="bibr" rid="bib8">Braudeau et al., 2011</xref>.</p></sec><sec id="s4-5"><title>Immunohistochemistry</title><p>Parvalbumin, SST and GFP staining were performed on 20–50 µm-thick slices. Briefly, mice were perfused with 0.9% NaCl solution containing Heparin and 4% paraformaldehyde (PFA). Brains were cryo-protected by placing them overnight in 30% sucrose solution and then frozen in Isopentane at a temperature &lt;-50°C. Brains were sliced with a freezing microtome (ThermoFisher HM450). Permeabilization in a blocking solution of PBT with 0.3% Triton and 10% Normal Goat Serum was done at room temperature for 2 hr. Slices were then incubated overnight (4°C) in the same blocking solution containing the primary rabbit anti-PV antibody (1:1000; Thermo Scientific) and mouse anti-SST antibody (1:250; Santa Cruz Biotechnologies). Slices were then rinsed three times in PBS (10 min each) at room temperature and incubated with goat anti-rabbit and a goat anti-mouse antibody (1:500; Jackson IR) coupled to Alexa-488 or 633 for 3.5 hr at room temperature. Slices were then rinsed three times in PBS (10 min each) at room temperature and coverslipped in mounting medium (Fluoromount, Sigma Aldrich F4680). Immunofluorescence was then observed with a slide scanner (Zeiss, Axio Scan.Z1).</p></sec><sec id="s4-6"><title>Morphological reconstruction</title><p>Biocytin Fills: To reliably reconstruct the fine axonal branches of cortical neurons, dedicated experiments were performed following the classical avidin-biotin-peroxidase method. Biocytin (Sigma) was added to the intracellular solution at a high concentration (5–10 mg/ml), which required extensive sonication. At the end of recordings, the patch pipette was removed carefully until obtaining an inside out patch. The slice was then left in the recording chamber for at least further 5–10 min to allow further diffusion. Slices were then fixed with 4% paraformaldehyde in phosphate buffer saline (PBS, Sigma) for at least 48 hr. Following fixation, slices were incubated with the avidin-biotin complex (Vector Labs) and a high concentration of detergent (Triton-X100, 5%) for at least two days before staining with 3,3′Diaminobenzidine (DAB, AbCam). Cells were then reconstructed and cortical layers delimited using Neurolucida 7 (MBF Bioscience) and the most up to date mouse atlas (Allen Institute).</p></sec><sec id="s4-7"><title>Data analysis</title><p>Electrophysiological and statistical analysis was performed using built-in and custom-written routines made for Igor Pro (WaveMetrics, Lake Oswego, OR, USA), MATLAB R2017b 9.3.0.713579 Natick, Massachusetts: The MathWorks Inc; Origin (Pro) 2016 OriginLab Corporation, Northampton, MA, USA; Prism version 7.00 for Windows, GraphPad Software, La Jolla California USA; and Python Software Foundation. Python Language Reference, version 3.6, available at <ext-link ext-link-type="uri" xlink:href="http://www.python.org">http://www.python.org.</ext-link></p></sec><sec id="s4-8"><title>Analysis of in vivo recordings</title><p>Traces obtained from juxtacellular recording were high pass filtered (cutoff: 5 Hz) and spikes were detected based on threshold = 1.5 mV. Spike rate was estimated as the total number of spikes detected divided by the total duration of the recording. The peak time (t<sub>peak</sub>) corresponding to each detected action potential was used to select the segment of LFP between: [t<sub>peak</sub>-100 ms to t<sub>peak</sub>+100 ms]. The instantaneous phase was estimated using Hilbert transform on decimated LFP and subsequently used to estimate phase locking. For LFP analysis, extracellular potentials were down-sampled (1 kHz) and low- pass filtered (cutoff frequency, 100 Hz). Power spectra were generated using a Hann window (window length: 4096 points, 50% overlap).</p><p>Phase locking was determined using pairwise phase consistency (PPC) estimation, defined as:<disp-formula id="equ1"><mml:math id="m1"><mml:mrow><mml:mi>P</mml:mi><mml:mi>P</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msubsup><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo>∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:msubsup><mml:mstyle displaystyle="true" mathsize="140%"><mml:mo>∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mi>i</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>θ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>θ</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>θ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>θ</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mo>.</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>N</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula></p><p>Where N is the total number of action potentials and θ<italic><sub>i</sub></italic> is the phase of the <italic>i</italic><sup>th</sup> spike and θ<italic><sub>j</sub></italic> the <italic>j</italic><sup>th</sup>.</p></sec><sec id="s4-9"><title>UP and DOWN states detection</title><p>Cortical states were detected as described elsewhere (<xref ref-type="bibr" rid="bib47">Ruiz-Mejias et al., 2011</xref>). Briefly, filtered and decimated LFP was used to calculate UP and DOWN state likelihood decision (or evidence) variable (S<sub>comb</sub>) based on low frequency (&lt;4 Hz) oscillation phase and high frequencies (20–100 Hz) composition of the LFP. To determine the thresholds to detect different cortical states (UP, Intermediate, DOWN) states, the distribution of the combined evidence variable,<inline-formula><mml:math id="inf1"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, was fitted by a mixture of three Gaussians, each representing their corresponding cortical state, UP (highest level of the signal), Intermediate (Intermediate level) and DOWN (lowest level of the signal). Periods of the combined signal, <inline-formula><mml:math id="inf2"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, that were above the UP threshold, <inline-formula><mml:math id="inf3"><mml:mrow><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi>U</mml:mi><mml:mi>P</mml:mi><mml:mo>−</mml:mo><mml:mi>L</mml:mi><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>3</mml:mn><mml:mo>*</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>U</mml:mi><mml:mi>P</mml:mi><mml:mo>−</mml:mo><mml:mi>L</mml:mi><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></inline-formula> were considered the periods of UP states. Similarly, the periods below the DOWN threshold, <inline-formula><mml:math id="inf4"><mml:mrow><mml:msub><mml:mi>μ</mml:mi><mml:mrow><mml:mi>D</mml:mi><mml:mi>O</mml:mi><mml:mi>W</mml:mi><mml:mi>N</mml:mi><mml:mo>−</mml:mo><mml:mi>L</mml:mi><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>3</mml:mn><mml:mo>*</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>D</mml:mi><mml:mi>O</mml:mi><mml:mi>W</mml:mi><mml:mi>N</mml:mi><mml:mo>−</mml:mo><mml:mi>L</mml:mi><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></inline-formula> were considered the periods of DOWN states (means and variances of the Gaussians are represented as <italic>μ<sub>UP</sub>, μ<sub>DOWN</sub></italic>, and <italic>σ<sub>UP</sub>, σ<sub>DOWN</sub></italic> for the up and down cortical states, respectively). Periods of UP and DOWN states were refined further by putting constraints on the interval between two states and duration of a state. Minimum interval between two states and duration of a state were set 50 and 70 ms, respectively.</p></sec><sec id="s4-10"><title>Analysis of slices electrophysiological recordings</title><p>Input resistance (R<sub>i</sub>) was estimated as the slope of the current to voltage relationship obtained with upon the injection of −25, 0 and 25 pA to a cell kept at resting potential. Membrane time constant was estimated fitting the time course of V<sub>memb</sub> after the injection of a 2 s, −25 pA current step.</p><p>We used protocols of increasing steps of current injection (−50 to 500 pA in steps of 25 or 50 pA and 2 s duration). Action potentials were detected using a threshold based routine. Threshold was set at 0 mV. Firing dynamics was evaluated fitting AP frequency versus current relationship (F-I curve) for somatic current injections from individual cells to a logarithmic function:<disp-formula id="equ2"><mml:math id="m2"><mml:mrow><mml:mi>f</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>I</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>*</mml:mo><mml:mi>ln</mml:mi><mml:mo>(</mml:mo><mml:mfrac><mml:mi>I</mml:mi><mml:mrow><mml:mi>r</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>o</mml:mi><mml:mi>b</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:math></disp-formula></p><p>Where <italic>I</italic> is the amount of injected current, the parameter gain represents the gain of the system and rheobase represents the minimal amount of current required to trigger an action potential. The first action potential evoked at rheobase was taken to measure amplitude, width and threshold. Threshold was considered as the potential at which dV/dt reached 10 mV/ms; amplitude was the difference between peak amplitude and threshold and half-width was the time interval between rise and decay phase measured at 50% of amplitude.</p><p>Action potential threshold was defined as the membrane potential value (V<sub>m</sub>) at which dV/dt becomes larger than 10 mV/ms. Action potential amplitude was defined as:<disp-formula id="equ3"><mml:math id="m3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>A</mml:mi><mml:mi>m</mml:mi><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mi>A</mml:mi><mml:mi>m</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>h</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mi>d</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula>where Amp<sub>peak</sub> was the AP peak potential. Action potential width was measured at 50% of amplitude.</p></sec><sec id="s4-11"><title>Statistical analysis</title><p>Normal distribution of samples was systematically assessed (Shapiro-Wilkinson normality test). Normal distributed samples were statistically compared using two-tailed Student’s <italic>t</italic> test unless otherwise stated. When data distribution was not normal we used two-tailed Mann Whitney U-test. Compiled data are reported and presented as whisker box plots the upper and lower whiskers representing the 90th and 10th percentiles, respectively, and the upper and lower boxes representing the 75th and 25th percentiles, respectively, and the horizontal line representing the median or the mean ± s.e.m., with single data points plotted. Differences were considered significant if p&lt;0.05 (*p&lt;0.05, **p&lt;0.01, ***p&lt;0.001).</p></sec><sec id="s4-12"><title>Dendritic inhibition</title><p>Evaluation of synaptic efficiency in the dendritic inhibitory loop composed by MCs and PNs.</p></sec><sec id="s4-13"><title>Perisomatic inhibition</title><p>Evaluation of synaptic efficiency in the perisomatic inhibitory loop composed by PV cells and PNs.</p><p>Ts65Dn in vivo activity.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Vikaas Sohal, Nelson Rebola and Maria del Mar Dierssen Sotos for critically reading this manuscript and Michele Giugliano for insightful discussions. We also thank the ICM technical facilities PHENO-ICMICE and iGENSEQ.</p><p>This work was supported by ‘Investissements d’avenir’ ANR-10-IAIHU-06, BBT-MOCONET; Agence Nationale de la Recherche (ANR-12-EMMA-0010 ; ANR-13-BSV4-0015-01; ANR-16-CE16-0007-02; ANR-17-CE16-0026-01; ANR-18-CE16-0001-01), Fondation Recherche Médicale (Equipe FRM DEQ20150331684 and EQU201903007860), NARSAD independent investigator grant, École des Neurosciences de Paris Ile-de-France and Fondation Lejeune (#1790). All animal work was conducted at the PHENO-ICMice facility. The PHENO-ICMICE Core is supported by 2 ‘Investissements d’avenir’ (ANR-10- IAIHU-06 and ANR-11-INBS-0011-NeurATRIS) and the ‘Fondation pour la Recherche Médicale’.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Software, Formal analysis, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Resources, Supervision, Funding acquisition, Validation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Software, Formal analysis, Supervision, Funding acquisition, Validation, Visualization, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: Experimental procedures followed National and European guidelines, and have been approved by the authors' institutional review boards (French Ministry of Research and Innovation, APAFIS#2599-2015110414316981v21). Every effort was made to minimize suffering.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-58731-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Source data files have been provided for: Figure 1, Figure 1–figure supplement 2, Figure 1–figure supplement 3, Figure 2, Figure 2–figure supplement 1, Figure 2–figure supplement 2, Figure 3, Figure 3–figure supplement 1, Figure 4, Figure 4–figure supplement 1 and Figure 5.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbas</surname> <given-names>AI</given-names></name><name><surname>Sundiang</surname> <given-names>MJM</given-names></name><name><surname>Henoch</surname> <given-names>B</given-names></name><name><surname>Morton</surname> <given-names>MP</given-names></name><name><surname>Bolkan</surname> <given-names>SS</given-names></name><name><surname>Park</surname> <given-names>AJ</given-names></name><name><surname>Harris</surname> <given-names>AZ</given-names></name><name><surname>Kellendonk</surname> <given-names>C</given-names></name><name><surname>Gordon</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Somatostatin interneurons facilitate Hippocampal-Prefrontal synchrony and prefrontal spatial encoding</article-title><source>Neuron</source><volume>100</volume><fpage>926</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.09.029</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alemany-González</surname> <given-names>M</given-names></name><name><surname>Gener</surname> <given-names>T</given-names></name><name><surname>Nebot</surname> <given-names>P</given-names></name><name><surname>Vilademunt</surname> <given-names>M</given-names></name><name><surname>Dierssen</surname> <given-names>M</given-names></name><name><surname>Puig</surname> <given-names>MV</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Prefrontal-hippocampal functional connectivity encodes recognition memory and is impaired in intellectual disability</article-title><source>PNAS</source><volume>117</volume><fpage>11788</fpage><lpage>11798</lpage><pub-id pub-id-type="doi">10.1073/pnas.1921314117</pub-id><pub-id pub-id-type="pmid">32393630</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname> <given-names>AB</given-names></name><name><surname>Thomson</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Synaptic alpha 5 subunit-containing GABAA receptors mediate IPSPs elicited by dendrite-preferring cells in rat neocortex</article-title><source>Cerebral Cortex</source><volume>18</volume><fpage>1260</fpage><lpage>1271</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhm160</pub-id><pub-id pub-id-type="pmid">17951598</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonarakis</surname> <given-names>SE</given-names></name><name><surname>Skotko</surname> <given-names>BG</given-names></name><name><surname>Rafii</surname> <given-names>MS</given-names></name><name><surname>Strydom</surname> <given-names>A</given-names></name><name><surname>Pape</surname> <given-names>SE</given-names></name><name><surname>Bianchi</surname> <given-names>DW</given-names></name><name><surname>Sherman</surname> <given-names>SL</given-names></name><name><surname>Reeves</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Down syndrome</article-title><source>Nature Reviews Disease Primers</source><volume>6</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.1038/s41572-019-0143-7</pub-id><pub-id pub-id-type="pmid">32029743</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atallah</surname> <given-names>BV</given-names></name><name><surname>Bruns</surname> <given-names>W</given-names></name><name><surname>Carandini</surname> <given-names>M</given-names></name><name><surname>Scanziani</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Parvalbumin-expressing interneurons linearly transform cortical responses to visual stimuli</article-title><source>Neuron</source><volume>73</volume><fpage>159</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.12.013</pub-id><pub-id pub-id-type="pmid">22243754</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aziz</surname> <given-names>NM</given-names></name><name><surname>Guedj</surname> <given-names>F</given-names></name><name><surname>Pennings</surname> <given-names>JLA</given-names></name><name><surname>Olmos-Serrano</surname> <given-names>JL</given-names></name><name><surname>Siegel</surname> <given-names>A</given-names></name><name><surname>Haydar</surname> <given-names>TF</given-names></name><name><surname>Bianchi</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and dp(16)1/Yey mouse models of down syndrome</article-title><source>Disease Models &amp; Mechanisms</source><volume>11</volume><elocation-id>dmm031013</elocation-id><pub-id pub-id-type="doi">10.1242/dmm.031013</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botta</surname> <given-names>P</given-names></name><name><surname>Demmou</surname> <given-names>L</given-names></name><name><surname>Kasugai</surname> <given-names>Y</given-names></name><name><surname>Markovic</surname> <given-names>M</given-names></name><name><surname>Xu</surname> <given-names>C</given-names></name><name><surname>Fadok</surname> <given-names>JP</given-names></name><name><surname>Lu</surname> <given-names>T</given-names></name><name><surname>Poe</surname> <given-names>MM</given-names></name><name><surname>Xu</surname> <given-names>L</given-names></name><name><surname>Cook</surname> <given-names>JM</given-names></name><name><surname>Rudolph</surname> <given-names>U</given-names></name><name><surname>Sah</surname> <given-names>P</given-names></name><name><surname>Ferraguti</surname> <given-names>F</given-names></name><name><surname>Lüthi</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Regulating anxiety with extrasynaptic inhibition</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>1493</fpage><lpage>1500</lpage><pub-id pub-id-type="doi">10.1038/nn.4102</pub-id><pub-id pub-id-type="pmid">26322928</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braudeau</surname> <given-names>J</given-names></name><name><surname>Delatour</surname> <given-names>B</given-names></name><name><surname>Duchon</surname> <given-names>A</given-names></name><name><surname>Pereira</surname> <given-names>PL</given-names></name><name><surname>Dauphinot</surname> <given-names>L</given-names></name><name><surname>de Chaumont</surname> <given-names>F</given-names></name><name><surname>Olivo-Marin</surname> <given-names>JC</given-names></name><name><surname>Dodd</surname> <given-names>RH</given-names></name><name><surname>Hérault</surname> <given-names>Y</given-names></name><name><surname>Potier</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in down syndrome mice</article-title><source>Journal of Psychopharmacology</source><volume>25</volume><fpage>1030</fpage><lpage>1042</lpage><pub-id pub-id-type="doi">10.1177/0269881111405366</pub-id><pub-id pub-id-type="pmid">21693554</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buzsáki</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>XJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mechanisms of gamma oscillations</article-title><source>Annual Review of Neuroscience</source><volume>35</volume><fpage>203</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-062111-150444</pub-id><pub-id pub-id-type="pmid">22443509</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardin</surname> <given-names>JA</given-names></name><name><surname>Carlén</surname> <given-names>M</given-names></name><name><surname>Meletis</surname> <given-names>K</given-names></name><name><surname>Knoblich</surname> <given-names>U</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Deisseroth</surname> <given-names>K</given-names></name><name><surname>Tsai</surname> <given-names>LH</given-names></name><name><surname>Moore</surname> <given-names>CI</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Driving fast-spiking cells induces gamma rhythm and controls sensory responses</article-title><source>Nature</source><volume>459</volume><fpage>663</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.1038/nature08002</pub-id><pub-id pub-id-type="pmid">19396156</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarti</surname> <given-names>L</given-names></name><name><surname>Best</surname> <given-names>TK</given-names></name><name><surname>Cramer</surname> <given-names>NP</given-names></name><name><surname>Carney</surname> <given-names>RS</given-names></name><name><surname>Isaac</surname> <given-names>JT</given-names></name><name><surname>Galdzicki</surname> <given-names>Z</given-names></name><name><surname>Haydar</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Olig1 and Olig2 triplication causes developmental brain defects in down syndrome</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>927</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1038/nn.2600</pub-id><pub-id pub-id-type="pmid">20639873</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>P</given-names></name><name><surname>Bush</surname> <given-names>D</given-names></name><name><surname>Schorge</surname> <given-names>S</given-names></name><name><surname>Good</surname> <given-names>M</given-names></name><name><surname>Canonica</surname> <given-names>T</given-names></name><name><surname>Shing</surname> <given-names>N</given-names></name><name><surname>Noy</surname> <given-names>S</given-names></name><name><surname>Wiseman</surname> <given-names>FK</given-names></name><name><surname>Burgess</surname> <given-names>N</given-names></name><name><surname>Tybulewicz</surname> <given-names>VLJ</given-names></name><name><surname>Walker</surname> <given-names>MC</given-names></name><name><surname>Fisher</surname> <given-names>EMC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Altered Hippocampal-Prefrontal neural dynamics in mouse models of down syndrome</article-title><source>Cell Reports</source><volume>30</volume><fpage>1152</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.12.065</pub-id><pub-id pub-id-type="pmid">31995755</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>G</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Zhao</surname> <given-names>X</given-names></name><name><surname>Ye</surname> <given-names>Q</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Tao</surname> <given-names>HW</given-names></name><name><surname>Rasch</surname> <given-names>MJ</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Distinct inhibitory circuits orchestrate cortical beta and gamma band oscillations</article-title><source>Neuron</source><volume>96</volume><fpage>1403</fpage><lpage>1418</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.11.033</pub-id><pub-id pub-id-type="pmid">29268099</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>KK</given-names></name><name><surname>Hoch</surname> <given-names>R</given-names></name><name><surname>Lee</surname> <given-names>AT</given-names></name><name><surname>Patel</surname> <given-names>T</given-names></name><name><surname>Rubenstein</surname> <given-names>JL</given-names></name><name><surname>Sohal</surname> <given-names>VS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Gamma rhythms link prefrontal interneuron dysfunction with cognitive inflexibility in dlx5/6+/-mice</article-title><source>Neuron</source><volume>85</volume><fpage>1332</fpage><lpage>1343</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.02.019</pub-id><pub-id pub-id-type="pmid">25754826</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname> <given-names>KA</given-names></name><name><surname>Clem</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Prefrontal somatostatin interneurons encode fear memory</article-title><source>Nature Neuroscience</source><volume>23</volume><elocation-id>61</elocation-id><pub-id pub-id-type="doi">10.1038/s41593-019-0552-7</pub-id><pub-id pub-id-type="pmid">31844314</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davisson</surname> <given-names>MT</given-names></name><name><surname>Schmidt</surname> <given-names>C</given-names></name><name><surname>Reeves</surname> <given-names>RH</given-names></name><name><surname>Irving</surname> <given-names>NG</given-names></name><name><surname>Akeson</surname> <given-names>EC</given-names></name><name><surname>Harris</surname> <given-names>BS</given-names></name><name><surname>Bronson</surname> <given-names>RT</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Segmental trisomy as a mouse model for down syndrome</article-title><source>Progress in Clinical and Biological Research</source><volume>384</volume><fpage>117</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">8115398</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawson</surname> <given-names>GR</given-names></name><name><surname>Maubach</surname> <given-names>KA</given-names></name><name><surname>Collinson</surname> <given-names>N</given-names></name><name><surname>Cobain</surname> <given-names>M</given-names></name><name><surname>Everitt</surname> <given-names>BJ</given-names></name><name><surname>MacLeod</surname> <given-names>AM</given-names></name><name><surname>Choudhury</surname> <given-names>HI</given-names></name><name><surname>McDonald</surname> <given-names>LM</given-names></name><name><surname>Pillai</surname> <given-names>G</given-names></name><name><surname>Rycroft</surname> <given-names>W</given-names></name><name><surname>Smith</surname> <given-names>AJ</given-names></name><name><surname>Sternfeld</surname> <given-names>F</given-names></name><name><surname>Tattersall</surname> <given-names>FD</given-names></name><name><surname>Wafford</surname> <given-names>KA</given-names></name><name><surname>Reynolds</surname> <given-names>DS</given-names></name><name><surname>Seabrook</surname> <given-names>GR</given-names></name><name><surname>Atack</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition</article-title><source>The Journal of Pharmacology and Experimental Therapeutics</source><volume>316</volume><fpage>1335</fpage><lpage>1345</lpage><pub-id pub-id-type="doi">10.1124/jpet.105.092320</pub-id><pub-id pub-id-type="pmid">16326923</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deleuze</surname> <given-names>C</given-names></name><name><surname>Bhumbra</surname> <given-names>GS</given-names></name><name><surname>Pazienti</surname> <given-names>A</given-names></name><name><surname>Lourenço</surname> <given-names>J</given-names></name><name><surname>Mailhes</surname> <given-names>C</given-names></name><name><surname>Aguirre</surname> <given-names>A</given-names></name><name><surname>Beato</surname> <given-names>M</given-names></name><name><surname>Bacci</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Strong preference for autaptic self-connectivity of neocortical PV interneurons facilitates their tuning to γ-oscillations</article-title><source>PLOS Biology</source><volume>17</volume><elocation-id>e3000419</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3000419</pub-id><pub-id pub-id-type="pmid">31483783</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiGuiseppi</surname> <given-names>C</given-names></name><name><surname>Hepburn</surname> <given-names>S</given-names></name><name><surname>Davis</surname> <given-names>JM</given-names></name><name><surname>Fidler</surname> <given-names>DJ</given-names></name><name><surname>Hartway</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>NR</given-names></name><name><surname>Miller</surname> <given-names>L</given-names></name><name><surname>Ruttenber</surname> <given-names>M</given-names></name><name><surname>Robinson</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Screening for autism spectrum disorders in children with down syndrome: population prevalence and screening test characteristics</article-title><source>Journal of Developmental and Behavioral Pediatrics : JDBP</source><volume>31</volume><fpage>181</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1097/DBP.0b013e3181d5aa6d</pub-id><pub-id pub-id-type="pmid">20375732</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duchon</surname> <given-names>A</given-names></name><name><surname>Gruart</surname> <given-names>A</given-names></name><name><surname>Albac</surname> <given-names>C</given-names></name><name><surname>Delatour</surname> <given-names>B</given-names></name><name><surname>Zorrilla de San Martin</surname> <given-names>J</given-names></name><name><surname>Delgado-García</surname> <given-names>JM</given-names></name><name><surname>Hérault</surname> <given-names>Y</given-names></name><name><surname>Potier</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Long-lasting correction of in vivo LTP and cognitive deficits of mice modelling down syndrome with an α5-selective GABAA inverse agonist</article-title><source>British Journal of Pharmacology</source><volume>177</volume><fpage>1106</fpage><lpage>1118</lpage><pub-id pub-id-type="doi">10.1111/bph.14903</pub-id><pub-id pub-id-type="pmid">31652355</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erisir</surname> <given-names>A</given-names></name><name><surname>Lau</surname> <given-names>D</given-names></name><name><surname>Rudy</surname> <given-names>B</given-names></name><name><surname>Leonard</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Function of specific K(+) channels in sustained high-frequency firing of fast-spiking neocortical interneurons</article-title><source>Journal of Neurophysiology</source><volume>82</volume><fpage>2476</fpage><lpage>2489</lpage><pub-id pub-id-type="doi">10.1152/jn.1999.82.5.2476</pub-id><pub-id pub-id-type="pmid">10561420</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname> <given-names>F</given-names></name><name><surname>Morishita</surname> <given-names>W</given-names></name><name><surname>Zuniga</surname> <given-names>E</given-names></name><name><surname>Nguyen</surname> <given-names>J</given-names></name><name><surname>Blank</surname> <given-names>M</given-names></name><name><surname>Malenka</surname> <given-names>RC</given-names></name><name><surname>Garner</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Pharmacotherapy for cognitive impairment in a mouse model of down syndrome</article-title><source>Nature Neuroscience</source><volume>10</volume><fpage>411</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1038/nn1860</pub-id><pub-id pub-id-type="pmid">17322876</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname> <given-names>F</given-names></name><name><surname>Nyhuis</surname> <given-names>CC</given-names></name><name><surname>Anand</surname> <given-names>P</given-names></name><name><surname>Demara</surname> <given-names>BI</given-names></name><name><surname>Ruby</surname> <given-names>NF</given-names></name><name><surname>Spanò</surname> <given-names>G</given-names></name><name><surname>Clark</surname> <given-names>C</given-names></name><name><surname>Edgin</surname> <given-names>JO</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Young children with down syndrome show normal development of circadian rhythms, but poor sleep efficiency: a cross-sectional study across the first 60 months of life</article-title><source>Sleep Medicine</source><volume>33</volume><fpage>134</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.sleep.2016.12.026</pub-id><pub-id pub-id-type="pmid">28449894</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giménez</surname> <given-names>S</given-names></name><name><surname>Videla</surname> <given-names>L</given-names></name><name><surname>Romero</surname> <given-names>S</given-names></name><name><surname>Benejam</surname> <given-names>B</given-names></name><name><surname>Clos</surname> <given-names>S</given-names></name><name><surname>Fernández</surname> <given-names>S</given-names></name><name><surname>Martínez</surname> <given-names>M</given-names></name><name><surname>Carmona-Iragui</surname> <given-names>M</given-names></name><name><surname>Antonijoan</surname> <given-names>RM</given-names></name><name><surname>Mayos</surname> <given-names>M</given-names></name><name><surname>Fortuna</surname> <given-names>A</given-names></name><name><surname>Peñacoba</surname> <given-names>P</given-names></name><name><surname>Plaza</surname> <given-names>V</given-names></name><name><surname>Osorio</surname> <given-names>RS</given-names></name><name><surname>Sharma</surname> <given-names>RA</given-names></name><name><surname>Bardés</surname> <given-names>I</given-names></name><name><surname>Rebillat</surname> <given-names>AS</given-names></name><name><surname>Lleó</surname> <given-names>A</given-names></name><name><surname>Blesa</surname> <given-names>R</given-names></name><name><surname>Videla</surname> <given-names>S</given-names></name><name><surname>Fortea</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Prevalence of sleep disorders in adults with down syndrome: a comparative study of Self-Reported, Actigraphic, and polysomnographic findings</article-title><source>Journal of Clinical Sleep Medicine</source><volume>14</volume><fpage>1725</fpage><lpage>1733</lpage><pub-id pub-id-type="doi">10.5664/jcsm.7382</pub-id><pub-id pub-id-type="pmid">30353801</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glykys</surname> <given-names>J</given-names></name><name><surname>Mody</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABA A receptor ␣ 5 subunit – Deficient Mice</article-title><source>Journal of Neurophysiology</source><volume>2005</volume><fpage>2796</fpage><lpage>2807</lpage><pub-id pub-id-type="doi">10.1152/jn.01122.2005</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannan</surname> <given-names>S</given-names></name><name><surname>Minere</surname> <given-names>M</given-names></name><name><surname>Harris</surname> <given-names>J</given-names></name><name><surname>Izquierdo</surname> <given-names>P</given-names></name><name><surname>Thomas</surname> <given-names>P</given-names></name><name><surname>Tench</surname> <given-names>B</given-names></name><name><surname>Smart</surname> <given-names>TG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>GABAAR isoform and subunit structural motifs determine synaptic and extrasynaptic receptor localisation</article-title><source>Neuropharmacology</source><volume>169</volume><elocation-id>107540</elocation-id><pub-id pub-id-type="doi">10.1016/j.neuropharm.2019.02.022</pub-id><pub-id pub-id-type="pmid">30794836</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hausrat</surname> <given-names>TJ</given-names></name><name><surname>Muhia</surname> <given-names>M</given-names></name><name><surname>Gerrow</surname> <given-names>K</given-names></name><name><surname>Thomas</surname> <given-names>P</given-names></name><name><surname>Hirdes</surname> <given-names>W</given-names></name><name><surname>Tsukita</surname> <given-names>S</given-names></name><name><surname>Heisler</surname> <given-names>FF</given-names></name><name><surname>Herich</surname> <given-names>L</given-names></name><name><surname>Dubroqua</surname> <given-names>S</given-names></name><name><surname>Breiden</surname> <given-names>P</given-names></name><name><surname>Feldon</surname> <given-names>J</given-names></name><name><surname>Schwarz</surname> <given-names>JR</given-names></name><name><surname>Yee</surname> <given-names>BK</given-names></name><name><surname>Smart</surname> <given-names>TG</given-names></name><name><surname>Triller</surname> <given-names>A</given-names></name><name><surname>Kneussel</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Radixin regulates synaptic GABAA receptor density and is essential for reversal learning and short-term memory</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>6872</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7872</pub-id><pub-id pub-id-type="pmid">25891999</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helfrich</surname> <given-names>RF</given-names></name><name><surname>Knight</surname> <given-names>RT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Oscillatory dynamics of prefrontal cognitive control</article-title><source>Trends in Cognitive Sciences</source><volume>20</volume><fpage>916</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1016/j.tics.2016.09.007</pub-id><pub-id pub-id-type="pmid">27743685</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herault</surname> <given-names>Y</given-names></name><name><surname>Delabar</surname> <given-names>JM</given-names></name><name><surname>Fisher</surname> <given-names>EMC</given-names></name><name><surname>Tybulewicz</surname> <given-names>VLJ</given-names></name><name><surname>Yu</surname> <given-names>E</given-names></name><name><surname>Brault</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Rodent models in down syndrome research: impact and future opportunities</article-title><source>Disease Models &amp; Mechanisms</source><volume>10</volume><fpage>1165</fpage><lpage>1186</lpage><pub-id pub-id-type="doi">10.1242/dmm.029728</pub-id><pub-id pub-id-type="pmid">28993310</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernández-González</surname> <given-names>S</given-names></name><name><surname>Ballestín</surname> <given-names>R</given-names></name><name><surname>López-Hidalgo</surname> <given-names>R</given-names></name><name><surname>Gilabert-Juan</surname> <given-names>J</given-names></name><name><surname>Blasco-Ibáñez</surname> <given-names>JM</given-names></name><name><surname>Crespo</surname> <given-names>C</given-names></name><name><surname>Nácher</surname> <given-names>J</given-names></name><name><surname>Varea</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Altered distribution of hippocampal interneurons in the murine down syndrome model Ts65Dn</article-title><source>Neurochemical Research</source><volume>40</volume><fpage>151</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1007/s11064-014-1479-8</pub-id><pub-id pub-id-type="pmid">25399236</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaiser</surname> <given-names>T</given-names></name><name><surname>Ting</surname> <given-names>JT</given-names></name><name><surname>Monteiro</surname> <given-names>P</given-names></name><name><surname>Feng</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Transgenic labeling of parvalbumin-expressing neurons with tdTomato</article-title><source>Neuroscience</source><volume>321</volume><fpage>236</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.08.036</pub-id><pub-id pub-id-type="pmid">26318335</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaguchi</surname> <given-names>Y</given-names></name><name><surname>Kubota</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Neurochemical features and synaptic connections of large physiologically-identified GABAergic cells in the rat frontal cortex</article-title><source>Neuroscience</source><volume>85</volume><fpage>677</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1016/S0306-4522(97)00685-4</pub-id><pub-id pub-id-type="pmid">9639265</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>D</given-names></name><name><surname>Jeong</surname> <given-names>H</given-names></name><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Ghim</surname> <given-names>JW</given-names></name><name><surname>Her</surname> <given-names>ES</given-names></name><name><surname>Lee</surname> <given-names>SH</given-names></name><name><surname>Jung</surname> <given-names>MW</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Distinct roles of parvalbumin- and Somatostatin-Expressing interneurons in working memory</article-title><source>Neuron</source><volume>92</volume><fpage>902</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.09.023</pub-id><pub-id pub-id-type="pmid">27746132</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>H</given-names></name><name><surname>Ährlund-Richter</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Deisseroth</surname> <given-names>K</given-names></name><name><surname>Carlén</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Prefrontal parvalbumin neurons in control of attention</article-title><source>Cell</source><volume>164</volume><fpage>208</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.11.038</pub-id><pub-id pub-id-type="pmid">26771492</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleschevnikov</surname> <given-names>AM</given-names></name><name><surname>Belichenko</surname> <given-names>PV</given-names></name><name><surname>Gall</surname> <given-names>J</given-names></name><name><surname>George</surname> <given-names>L</given-names></name><name><surname>Nosheny</surname> <given-names>R</given-names></name><name><surname>Maloney</surname> <given-names>MT</given-names></name><name><surname>Salehi</surname> <given-names>A</given-names></name><name><surname>Mobley</surname> <given-names>WC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of down syndrome</article-title><source>Neurobiology of Disease</source><volume>45</volume><fpage>683</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2011.10.009</pub-id><pub-id pub-id-type="pmid">22062771</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larkum</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A cellular mechanism for cortical associations: an organizing principle for the cerebral cortex</article-title><source>Trends in Neurosciences</source><volume>36</volume><fpage>141</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2012.11.006</pub-id><pub-id pub-id-type="pmid">23273272</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>NR</given-names></name><name><surname>Anand</surname> <given-names>P</given-names></name><name><surname>Will</surname> <given-names>E</given-names></name><name><surname>Adeyemi</surname> <given-names>EI</given-names></name><name><surname>Clasen</surname> <given-names>LS</given-names></name><name><surname>Blumenthal</surname> <given-names>JD</given-names></name><name><surname>Giedd</surname> <given-names>JN</given-names></name><name><surname>Daunhauer</surname> <given-names>LA</given-names></name><name><surname>Fidler</surname> <given-names>DJ</given-names></name><name><surname>Edgin</surname> <given-names>JO</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Everyday executive functions in down syndrome from early childhood to young adulthood: evidence for both unique and shared characteristics compared to youth with sex chromosome trisomy (XXX and XXY)</article-title><source>Frontiers in Behavioral Neuroscience</source><volume>9</volume><elocation-id>264</elocation-id><pub-id pub-id-type="doi">10.3389/fnbeh.2015.00264</pub-id><pub-id pub-id-type="pmid">26539087</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovett-Barron</surname> <given-names>M</given-names></name><name><surname>Turi</surname> <given-names>GF</given-names></name><name><surname>Kaifosh</surname> <given-names>P</given-names></name><name><surname>Lee</surname> <given-names>PH</given-names></name><name><surname>Bolze</surname> <given-names>F</given-names></name><name><surname>Sun</surname> <given-names>XH</given-names></name><name><surname>Nicoud</surname> <given-names>JF</given-names></name><name><surname>Zemelman</surname> <given-names>BV</given-names></name><name><surname>Sternson</surname> <given-names>SM</given-names></name><name><surname>Losonczy</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Regulation of neuronal input transformations by tunable dendritic inhibition</article-title><source>Nature Neuroscience</source><volume>15</volume><fpage>423</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1038/nn.3024</pub-id><pub-id pub-id-type="pmid">22246433</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>Y</given-names></name><name><surname>Hu</surname> <given-names>H</given-names></name><name><surname>Berrebi</surname> <given-names>AS</given-names></name><name><surname>Mathers</surname> <given-names>PH</given-names></name><name><surname>Agmon</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Distinct subtypes of somatostatin-containing neocortical interneurons revealed in transgenic mice</article-title><source>Journal of Neuroscience</source><volume>26</volume><fpage>5069</fpage><lpage>5082</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0661-06.2006</pub-id><pub-id pub-id-type="pmid">16687498</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martínez-Cué</surname> <given-names>C</given-names></name><name><surname>Martínez</surname> <given-names>P</given-names></name><name><surname>Rueda</surname> <given-names>N</given-names></name><name><surname>Vidal</surname> <given-names>R</given-names></name><name><surname>García</surname> <given-names>S</given-names></name><name><surname>Vidal</surname> <given-names>V</given-names></name><name><surname>Corrales</surname> <given-names>A</given-names></name><name><surname>Montero</surname> <given-names>JA</given-names></name><name><surname>Pazos</surname> <given-names>Á</given-names></name><name><surname>Flórez</surname> <given-names>J</given-names></name><name><surname>Gasser</surname> <given-names>R</given-names></name><name><surname>Thomas</surname> <given-names>AW</given-names></name><name><surname>Honer</surname> <given-names>M</given-names></name><name><surname>Knoflach</surname> <given-names>F</given-names></name><name><surname>Trejo</surname> <given-names>JL</given-names></name><name><surname>Wettstein</surname> <given-names>JG</given-names></name><name><surname>Hernández</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome</article-title><source>Journal of Neuroscience</source><volume>33</volume><fpage>3953</fpage><lpage>3966</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1203-12.2013</pub-id><pub-id pub-id-type="pmid">23447605</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname> <given-names>A</given-names></name><name><surname>Blank</surname> <given-names>M</given-names></name><name><surname>Madison</surname> <given-names>DV</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Developmentally altered inhibition in Ts65Dn, a mouse model of down syndrome</article-title><source>Brain Research</source><volume>1440</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2011.12.034</pub-id><pub-id pub-id-type="pmid">22284618</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okaty</surname> <given-names>BW</given-names></name><name><surname>Miller</surname> <given-names>MN</given-names></name><name><surname>Sugino</surname> <given-names>K</given-names></name><name><surname>Hempel</surname> <given-names>CM</given-names></name><name><surname>Nelson</surname> <given-names>SB</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Transcriptional and electrophysiological maturation of neocortical fast-spiking GABAergic interneurons</article-title><source>Journal of Neuroscience</source><volume>29</volume><fpage>7040</fpage><lpage>7052</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0105-09.2009</pub-id><pub-id pub-id-type="pmid">19474331</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olmos-Serrano</surname> <given-names>JL</given-names></name><name><surname>Kang</surname> <given-names>HJ</given-names></name><name><surname>Tyler</surname> <given-names>WA</given-names></name><name><surname>Silbereis</surname> <given-names>JC</given-names></name><name><surname>Cheng</surname> <given-names>F</given-names></name><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>Pletikos</surname> <given-names>M</given-names></name><name><surname>Jankovic-Rapan</surname> <given-names>L</given-names></name><name><surname>Cramer</surname> <given-names>NP</given-names></name><name><surname>Galdzicki</surname> <given-names>Z</given-names></name><name><surname>Goodliffe</surname> <given-names>J</given-names></name><name><surname>Peters</surname> <given-names>A</given-names></name><name><surname>Sethares</surname> <given-names>C</given-names></name><name><surname>Delalle</surname> <given-names>I</given-names></name><name><surname>Golden</surname> <given-names>JA</given-names></name><name><surname>Haydar</surname> <given-names>TF</given-names></name><name><surname>Sestan</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination</article-title><source>Neuron</source><volume>89</volume><fpage>1208</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.01.042</pub-id><pub-id pub-id-type="pmid">26924435</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olmos-Serrano</surname> <given-names>JL</given-names></name><name><surname>Tyler</surname> <given-names>WA</given-names></name><name><surname>Cabral</surname> <given-names>HJ</given-names></name><name><surname>Haydar</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Longitudinal measures of cognition in the Ts65Dn mouse: refining windows and defining modalities for therapeutic intervention in down syndrome</article-title><source>Experimental Neurology</source><volume>279</volume><fpage>40</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2016.02.005</pub-id><pub-id pub-id-type="pmid">26854932</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrenoud</surname> <given-names>Q</given-names></name><name><surname>Pennartz</surname> <given-names>CM</given-names></name><name><surname>Gentet</surname> <given-names>LJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Membrane potential dynamics of spontaneous and visually evoked gamma activity in V1 of awake mice</article-title><source>PLOS Biology</source><volume>14</volume><elocation-id>e1002383</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1002383</pub-id><pub-id pub-id-type="pmid">26890123</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Royer</surname> <given-names>S</given-names></name><name><surname>Zemelman</surname> <given-names>BV</given-names></name><name><surname>Losonczy</surname> <given-names>A</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Chance</surname> <given-names>F</given-names></name><name><surname>Magee</surname> <given-names>JC</given-names></name><name><surname>Buzsáki</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Control of timing, rate and bursts of hippocampal place cells by dendritic and somatic inhibition</article-title><source>Nature Neuroscience</source><volume>15</volume><fpage>769</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1038/nn.3077</pub-id><pub-id pub-id-type="pmid">22446878</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-Mejias</surname> <given-names>M</given-names></name><name><surname>Ciria-Suarez</surname> <given-names>L</given-names></name><name><surname>Mattia</surname> <given-names>M</given-names></name><name><surname>Sanchez-Vives</surname> <given-names>MV</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Slow and fast rhythms generated in the cerebral cortex of the anesthetized mouse</article-title><source>Journal of Neurophysiology</source><volume>106</volume><fpage>2910</fpage><lpage>2921</lpage><pub-id pub-id-type="doi">10.1152/jn.00440.2011</pub-id><pub-id pub-id-type="pmid">21880935</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname> <given-names>JM</given-names></name><name><surname>Knoflach</surname> <given-names>F</given-names></name><name><surname>Hernandez</surname> <given-names>MC</given-names></name><name><surname>Bischofberger</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dendrite-targeting interneurons control synaptic NMD<sub>A</sub>-receptor activation vi<sub>a</sub> nonlinear α5-GABAA receptors</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>3576</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06004-8</pub-id><pub-id pub-id-type="pmid">30177704</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname> <given-names>JM</given-names></name><name><surname>Knoflach</surname> <given-names>F</given-names></name><name><surname>Hernandez</surname> <given-names>MC</given-names></name><name><surname>Bischofberger</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Enhanced dendritic inhibition and impaired NMDAR activation in a mouse model of down syndrome</article-title><source>The Journal of Neuroscience</source><volume>39</volume><fpage>5210</fpage><lpage>5221</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2723-18.2019</pub-id><pub-id pub-id-type="pmid">31000585</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serwanski</surname> <given-names>DR</given-names></name><name><surname>Miralles</surname> <given-names>CP</given-names></name><name><surname>Christie</surname> <given-names>SB</given-names></name><name><surname>Mehta</surname> <given-names>AK</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>De Blas</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Synaptic and nonsynaptic localization of GABAA receptors containing the alpha5 subunit in the rat brain</article-title><source>The Journal of Comparative Neurology</source><volume>499</volume><fpage>458</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1002/cne.21115</pub-id><pub-id pub-id-type="pmid">16998906</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silberberg</surname> <given-names>G</given-names></name><name><surname>Markram</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Disynaptic inhibition between neocortical pyramidal cells mediated by martinotti cells</article-title><source>Neuron</source><volume>53</volume><fpage>735</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2007.02.012</pub-id><pub-id pub-id-type="pmid">17329212</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohal</surname> <given-names>VS</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Yizhar</surname> <given-names>O</given-names></name><name><surname>Deisseroth</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Parvalbumin neurons and gamma rhythms enhance cortical circuit performance</article-title><source>Nature</source><volume>459</volume><fpage>698</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1038/nature07991</pub-id><pub-id pub-id-type="pmid">19396159</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sternfeld</surname> <given-names>F</given-names></name><name><surname>Carling</surname> <given-names>RW</given-names></name><name><surname>Jelley</surname> <given-names>RA</given-names></name><name><surname>Ladduwahetty</surname> <given-names>T</given-names></name><name><surname>Merchant</surname> <given-names>KJ</given-names></name><name><surname>Moore</surname> <given-names>KW</given-names></name><name><surname>Reeve</surname> <given-names>AJ</given-names></name><name><surname>Street</surname> <given-names>LJ</given-names></name><name><surname>O'Connor</surname> <given-names>D</given-names></name><name><surname>Sohal</surname> <given-names>B</given-names></name><name><surname>Atack</surname> <given-names>JR</given-names></name><name><surname>Cook</surname> <given-names>S</given-names></name><name><surname>Seabrook</surname> <given-names>G</given-names></name><name><surname>Wafford</surname> <given-names>K</given-names></name><name><surname>Tattersall</surname> <given-names>FD</given-names></name><name><surname>Collinson</surname> <given-names>N</given-names></name><name><surname>Dawson</surname> <given-names>GR</given-names></name><name><surname>Castro</surname> <given-names>JL</given-names></name><name><surname>MacLeod</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancers</article-title><source>Journal of Medicinal Chemistry</source><volume>47</volume><fpage>2176</fpage><lpage>2179</lpage><pub-id pub-id-type="doi">10.1021/jm031076j</pub-id><pub-id pub-id-type="pmid">15084116</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname> <given-names>R</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Rudy</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>GABAergic interneurons in the neocortex: from cellular properties to circuits</article-title><source>Neuron</source><volume>91</volume><fpage>260</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.06.033</pub-id><pub-id pub-id-type="pmid">27477017</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valbuena</surname> <given-names>S</given-names></name><name><surname>García</surname> <given-names>Á</given-names></name><name><surname>Mazier</surname> <given-names>W</given-names></name><name><surname>Paternain</surname> <given-names>AV</given-names></name><name><surname>Lerma</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Unbalanced dendritic inhibition of CA1 neurons drives spatial-memory deficits in the Ts2Cje down syndrome model</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>4991</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-13004-9</pub-id><pub-id pub-id-type="pmid">31676751</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veit</surname> <given-names>J</given-names></name><name><surname>Hakim</surname> <given-names>R</given-names></name><name><surname>Jadi</surname> <given-names>MP</given-names></name><name><surname>Sejnowski</surname> <given-names>TJ</given-names></name><name><surname>Adesnik</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cortical gamma band synchronization through somatostatin interneurons</article-title><source>Nature Neuroscience</source><volume>20</volume><fpage>951</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1038/nn.4562</pub-id><pub-id pub-id-type="pmid">28481348</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinck</surname> <given-names>M</given-names></name><name><surname>van Wingerden</surname> <given-names>M</given-names></name><name><surname>Womelsdorf</surname> <given-names>T</given-names></name><name><surname>Fries</surname> <given-names>P</given-names></name><name><surname>Pennartz</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The pairwise phase consistency: a bias-free measure of rhythmic neuronal synchronization</article-title><source>NeuroImage</source><volume>51</volume><fpage>112</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.01.073</pub-id><pub-id pub-id-type="pmid">20114076</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiseman</surname> <given-names>FK</given-names></name><name><surname>Al-Janabi</surname> <given-names>T</given-names></name><name><surname>Hardy</surname> <given-names>J</given-names></name><name><surname>Karmiloff-Smith</surname> <given-names>A</given-names></name><name><surname>Nizetic</surname> <given-names>D</given-names></name><name><surname>Tybulewicz</surname> <given-names>VL</given-names></name><name><surname>Fisher</surname> <given-names>EM</given-names></name><name><surname>Strydom</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A genetic cause of alzheimer disease: mechanistic insights from down syndrome</article-title><source>Nature Reviews Neuroscience</source><volume>16</volume><fpage>564</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1038/nrn3983</pub-id><pub-id pub-id-type="pmid">26243569</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zorrilla de San Martin</surname> <given-names>J</given-names></name><name><surname>Delabar</surname> <given-names>JM</given-names></name><name><surname>Bacci</surname> <given-names>A</given-names></name><name><surname>Potier</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>GABAergic over-inhibition, a promising hypothesis for cognitive deficits in down syndrome</article-title><source>Free Radical Biology and Medicine</source><volume>114</volume><fpage>33</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2017.10.002</pub-id><pub-id pub-id-type="pmid">28993272</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.58731.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Nelson</surname><given-names>Sacha B</given-names></name><role>Reviewing Editor</role><aff><institution>Brandeis University</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Nelson</surname><given-names>Sacha B</given-names></name><role>Reviewer</role><aff><institution>Brandeis University</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Bischofberger</surname><given-names>Josef</given-names> </name><role>Reviewer</role><aff><institution>University of Basel</institution><country>Switzerland</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>Down Syndrome is a developmental disorder due to a chromosomal abnormality which can be modeled in mice. Recent work has suggested that the intellectual disability results from excess inhibition in brain circuits. The authors use elegant physiological methods to provide direct evidence for the proposed over-inhibition in a mouse model of Down Syndrome and identify specific changes differently affecting two well studied classes of GABAergic interneurons.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, including Sacha B Nelson as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Gary Westbrook as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Josef Bischofberger (Reviewer #2). The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in <italic>eLife</italic> but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.</p><p>Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in <italic>eLife</italic>, either of which would be linked to the original paper.</p><p>Summary:</p><p>The concept of &quot;E/I balance&quot; has dominated discussions of the etiology of developmental disorders involving intellectual disability and Autism Spectrum Disorders. But many have rightly complained that this concept is poorly defined and poorly specified. The disorder Down Syndrome (DS) is especially interesting in this regard, both because it is the most common genetic syndrome causing intellectual disability and because pharmacological studies in mice have argued for enhanced inhibition as an important cause. The present study presents the first direct evidence for enhanced inhibition in mice that model the trisomy underlying DS. The authors use a rigorous approach involving paired recordings between identified types of neurons and identify specific synaptic and intrinsic changes in two important subpopulations of cortical interneurons; the Sst-positive Martinotti cells, and Pvalb-expressing basket cells.</p><p>Revisions for this paper:</p><p>The authors should make textual changes to address the key points raised by the three reviewers. Specifically,</p><p>1) Clarify and better discuss the limitations and caveats to the experiments involving pharmacological manipulation of enhanced dendritic inhibition.</p><p>2) Provide further analyses, clarification and discussion of the alterations in Pvalb-neuron excitability, along the lines suggested by reviewers #2 and #3 below.</p><p>3) Enhance the discussion of the final figure to better integrate these results into the rest of the paper.</p><p>The logic of the requested textual revisions is explained in the concerns of the reviewers and so those are included below.</p><p>Revisions expected in follow-up work:</p><p>If available, follow up recordings in older animals would add to the impact of the work as would follow up pharmacology studies.</p><p><italic>Reviewer #1:</italic></p><p>The authors provide direct evidence for the proposed over-inhibition in a mouse model of Down Syndrome and identify specific changes differently affecting two well studied classes of GABAergic interneurons. The results are robust and well-illustrated and the experiments are rigorous and well designed.</p><p>I have mainly minor suggestions for improving the manuscript. The most significant concern is that the English usage would benefit from careful editing.</p><p><italic>Reviewer #2:</italic></p><p>The new paper “Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down Syndrome” investigates how altered synaptic transmission in prefrontal cortex (PFC) might impact on cortical network activity in Down Syndrome. Using elegant electrophysiological paired recordings of synaptically coupled Martinotti-cells, PV-interneurons and pyramidal cells, the authors nicely show that dendritic inhibition is enhanced in the PFC. By contrast, peri-somatic inhibition is relatively normal. Furthermore, it is claimed that the excitability of PV-basket cells is increased affecting cortical γ-oscillations in anesthetized mice. To support these later claims, some more analysis is necessary.</p><p>1) Increased dendritic inhibition. This first part is very convincing in general. However, I was wondering about the 5-fold increase in synaptic charge, while peak amplitudes are only 3-times larger (Figure 1C). Is the decay time course slower in TS-mice? Furthermore, I could not find any information about the used GABA receptor modulator (a5IA). Is it L-822179 (PubChem CID 6918451)? There are many inverse agonists/modulators of GABAa5 receptors available. It is important that the authors precisely specify which drug and from what source. Finally, the authors should refer correctly to Schulz et al., 2019 and discuss that increased dendritic inhibition via GABAa5 receptors was also found in CA1 pyramidal cells of Ts65Dn mice.</p><p>2) PV-firing. Firstly, I am surprised by the control data of PV-cells in Figure 4. It seems that there is no defined rheobase in Figure 4B in contrast to the traces shown in Figure 4A black. Did the authors record form separate populations of PV-interneurons which distorts the average FI-curve? It would be important to analyze the FI-curves of different cells separately (as for example performed in Schulz et al., 2019). This will allow to calculate mean values (and medians) for rheobase and gain. A histogram (or cumulative distribution) of rheobase and gain will show the presence of different populations of cells in control and in Ts65Dn. To do so, the formula in subsection “Analysis of slices electrophysiological recordings” should be replaced by a more appropriate function, which includes a rheobase and without a base firing which is zero anyway (for example F = gain*ln(I/rheobase)). Second, the mice for slices are rather young (P18-P25). In adult animals, cortical PV-tdTom cells appear to show a mean Rin of 118 MOhm, an AP half duration of 0.5 ms and a taum of 7.2 ms (Kaiser et al., 2016). The control animals in the present study show consistently larger values. The values in Ts65Dn mice are further increased. Is it possible that PV cells of TS animals are just delayed in development? A first indication could be a correlative analysis plotting AP with, Rin, rheobase, gain and max firing frequency against animal age (P18-P25) to see whether there are significant correlations. The best would be slice recordings using older animals (&gt; 4 weeks), to see whether the differences disappear.</p><p>3) in vivo field potentials. The field potential analysis is only loosely connected to the rest of the paper. How do we know whether “alterations in cortical GABA circuits underlie the abnormal network activity” and increased γ-power in the in vivo LFPs? Furthermore, the authors discuss these data in the context of temporal coding and cognition. The slow waves during urethane anesthesia (1-4Hz) resembles slow wave sleep, which is relevant for memory consolidation. The authors should discuss the new paper by Alemany-Gonzalez et al., 2020 (PNAS 117:11788-11798), which show disturbed slow wave sleep oscillations in Ts65Dn mice. Similar to the present study they find increased γ power in PFC during slow wave sleep (Alemany-Gonzalez, Figure 2B), which could be related to the well-known sleep disturbances in DS patients.</p><p><italic>Reviewer #3:</italic></p><p>The authors present a clearly written, technically sound and very interesting study in which they demonstrate substantial changes in the prefrontal cortex inhibitory circuitry of a well-characterized transgenic Down Syndrome model. They show an aberrant dendritic inhibitory circuitry caused by an increased in synaptic transmission from and to Martinotti cells in the medial prefrontal cortex and changes in excitability of perisomatic inhibitory interneurons without apparent changes in synaptic properties. Finally, they demonstrate a strong decrease in principal cell activity on the medial prefrontal cortex of urethane anesthetized Ts mice and increase coupling to γ oscillations.</p><p>I find the study interesting and suitable for publication in <italic>eLife</italic>. It gives a detailed description of the inhibitory circuitry in the Ts mice and provides new in vivo evidence supporting the theory of over-inhibition as a main cause for cognitive deficits in DS. Nevertheless, there are some issues I think should be addressed first.</p><p>1) There is a mismatch between the age of animals used for in vitro and in vivo recordings. Down syndrome is a developmental disease, and it could be that interneuron development might take more time than in WT animals. PV positive interneurons are known to develop in the hippocampus during the first 4 postnatal weeks, bringing the question if the abnormalities observed in this study remain during adulthood. I suggest performing some of the main in vitro experiments for parvalbumin and somatostatin interneurons in slices from adult animals.</p><p>2) Another concern relates to the final conclusion of the paper, which correlates the in vitro observed abnormalities in inhibition with the decreased activity of principal cells. Although this might be the most rational assumption, I would appreciate evidence to make this hypothesis more likely, considering that DS mice also show changes in spine density, NMDA receptor expression in principal cells and increase threshold for firing as shown in this study. This could be performed by:</p><p>– Evaluating the effect of α5IA injection on principal cell activity in Eu and Ts mice.</p><p>– Performing recordings from identified interneurons in vivo in Eu and Ts mice.</p><p>– Test the effects of specific inhibition of parvalbumin or somatostatin interneurons on the activity of pyramidal cells in Eu and Ts mice.</p><p>A more comprehensive discussion addressing these issues might also be sufficient in case experiments are not feasible in a reasonable time frame.</p><p>3) The concentration of α5IA of 100 nm seems not to provide the highest specificity of the drug, having a milder but significant effect in receptors containing the α3 and α1 subunits (Dawson et al., 2005). Considering the general importance that this strong and very specific effect may have for the community, and the sparse literature using this drug in vitro I would appreciate a better characterization of this particular experiment.</p><p>– Does α5IA changes the kinetics of the GABAergic response?</p><p>– Are PV-mediated IPSCs affected by this concentration of α5IA?</p><p>– Does the α5IA dependent response shows voltage-dependency as has been reported (Schultz et al., 2019)</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.58731.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>The authors provide direct evidence for the proposed over-inhibition in a mouse model of Down Syndrome and identify specific changes differently affecting two well studied classes of GABAergic interneurons. The results are robust and well-illustrated and the experiments are rigorous and well designed.</p><p>I have mainly minor suggestions for improving the manuscript. The most significant concern is that the English usage would benefit from careful editing.</p></disp-quote><p>We have revised the English language throughout the manuscript and we asked a native speaker to read it. We hope the revised text is much clearer than the previous version.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>The new paper “Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down Syndrome” investigates how altered synaptic transmission in prefrontal cortex (PFC) might impact on cortical network activity in Down Syndrome. Using elegant electrophysiological paired recordings of synaptically coupled Martinotti-cells, PV-interneurons and pyramidal cells, the authors nicely show that dendritic inhibition is enhanced in the PFC. By contrast, peri-somatic inhibition is relatively normal. Furthermore, it is claimed that the excitability of PV-basket cells is increased affecting cortical γ-oscillations in anesthetized mice. To support these later claims, some more analysis is necessary.</p><p>1) Increased dendritic inhibition. This first part is very convincing in general. However, I was wondering about the 5-fold increase in synaptic charge, while peak amplitudes are only 3-times larger (Figure 1C). Is the decay time course slower in TS-mice?</p></disp-quote><p>Whereas the amplitude was calculated on the first synaptic response, the charge was measured over the entire train. We have measured the kinetics of MC-PN uIPSCs. We found no significant differences in isolated uIPSC decay time constant in Eu vs. Ts mice (see the new Figure 1—figure supplement 2). We found a significant increase of uIPSC rise-times in Eu vs Ts. This could be ascribed to a more distal location of MC-PN synapses on dendrites of Ts mice. Although this change could in principle account for, at least in part, an increase in synaptic charge, the magnitude of this change is unlikely to account for a 5-fold increase.</p><p>We speculate that a 5-fold increase of synaptic charge is due to one or a combination of different non-linearities that are dynamically emerging during a spike train: (i) recruitment of peri- or extrasynaptic GABA<sub>A</sub>Rs due to enhanced release of GABA; (ii) changes in postsynaptic receptors occupation and desensitization. Complex interplays between these factors occur at distal dendrites, where we have poor voltage control due to space-clamping constraints. Future studies will be necessary to pinpoint the exact biophysical and anatomical alterations underlying the prominent increase of dendritic inhibition operated by MCs in DS.</p><p>We have generated a new figure supplement to Figure 1 (Figure 1—figure supplement 2), detailing this finding. We have described (in subsection “Synaptic enhancement of dendritic inhibition in DS”) and integrated this new analysis to the discussion in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Furthermore, I could not find any information about the used GABA receptor modulator (a5IA). Is it L-822179 (PubChem CID 6918451)? There are many inverse agonists/modulators of GABAa5 receptors available. It is important that the authors precisely specify which drug and from what source.</p></disp-quote><p>The α5IA, an inverse antagonist of α5-containing GABAA receptors used in our study corresponds to the molecule ID:4095 (IUPHAR/BPS), also named L-822179, or CID 6918451 in PubChem. This has been detailed in the Materials and methods section of the revised manuscript, with the appropriate references.</p><disp-quote content-type="editor-comment"><p>Finally, the authors should refer correctly to Schulz et al., 2019 and discuss that increased dendritic inhibition via GABAa5 receptors was also found in CA1 pyramidal cells of Ts65Dn mice.</p></disp-quote><p>We thank the reviewer for pointing this out. We have correctly addressed this paper in the revised manuscript (Discussions section).</p><disp-quote content-type="editor-comment"><p>2) PV-firing. Firstly, I am surprised by the control data of PV-cells in Figure 4. It seems that there is no defined rheobase in Figure 4B in contrast to the traces shown in Figure 4A black. Did the authors record form separate populations of PV-interneurons which distorts the average FI-curve? It would be important to analyze the FI-curves of different cells separately (as for example performed in Schulz et al., 2019). This will allow to calculate mean values (and medians) for rheobase and gain. A histogram (or cumulative distribution) of rheobase and gain will show the presence of different populations of cells in control and in Ts65Dn. To do so, the formula in subsection “Analysis of slices electrophysiological recordings” should be replaced by a more appropriate function, which includes a rheobase and without a base firing which is zero anyway (for example F = gain*ln(I/rheobase)).</p></disp-quote><p>We have re-analyzed f-i curves as suggested by the reviewer. The new Figure 4 includes two representative examples of f-i curves in the two genotypes, fitted with the function suggested by the reviewer (panel b). Moreover, population data relative to rheobase and gain are shown in box-plot panels (left panel in c). This new analysis is consistent with a strong alteration of PV-cell excitability and firing dynamics in Ts mice. We have detailed this new analysis in the revised manuscript (subsection “Excitability of PV cells, and not their perisomatic control of PNs, is strongly altered in Ts mice”).</p><disp-quote content-type="editor-comment"><p>Second, the mice for slices are rather young (P18-P25). In adult animals, cortical PV-tdTom cells appear to show a mean Rin of 118 MOhm, an AP half duration of 0.5 ms and a taum of 7.2 ms (Kaiser et al., 2016). The control animals in the present study show consistently larger values. The values in Ts65Dn mice are further increased. Is it possible that PV cells of TS animals are just delayed in development? A first indication could be a correlative analysis plotting AP with, Rin, rheobase, gain and max firing frequency against animal age (P18-P25) to see whether there are significant correlations. The best would be slice recordings using older animals (&gt; 4 weeks), to see whether the differences disappear.</p></disp-quote><p>The reviewer raises an excellent point. Indeed, active and passive properties of PV cells of Ts mice are consistent with an immature phenotype (Okaty et al., 2009). We performed a correlation analysis of the passive properties and excitability with age as suggested. In Eu mice, we found that input resistance, tau membrane and AP half width change along this period of development into values similar to those reported by Okaty et al., 2009 and Kaiser et al., 2016. We have added a figure supplement to Figure 4 illustrating this developmental profile (see Figure 4—figure supplement 2).</p><p>Importantly, if we confine our analysis in the older time window of our recordings (P23-25), we found that differences in AP width, input resistance and membrane time constant remain starkly different. We include <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref> and <xref ref-type="table" rid="resptable1">Author response table 1</xref> illustrating this finding at this age. We also include the values of the Kaiser paper obtained in the somatosensory cortex of adult mice. Overall, this analysis excludes potential effect of a bias in the age composition of our sample and validates our interpretation.</p><fig id="sa2fig1"><label>Author response image 1.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-resp-fig1-v2.tif"/></fig><table-wrap id="resptable1" position="anchor"><label>Author response table 1.</label><table frame="hsides" rules="groups"><thead><tr><th/><th>Eu (n = 8) P23-25</th><th>Ts (n = 10) P23-25</th><th>P value*</th><th>Kaiser et al. 2016<sup>§</sup> P45-90</th></tr></thead><tbody><tr><td>Ri (MΩ)</td><td>94.6 ± 6.7</td><td>200.3 ± 45.3</td><td>p = 0.0034</td><td>119 ± 4.0</td></tr><tr><td>τm (ms)</td><td>6.9 ± 0.9</td><td>25.7 ± 4.2</td><td>p = 0.0004</td><td>7.2 ± 0.2</td></tr><tr><td>AP width (ms)</td><td>0.66 ± 0.03</td><td>1.44 ± 0.20</td><td>p = 0.0026</td><td>0.5 ± 0.01</td></tr></tbody></table></table-wrap><p>*Two-sided Mann Whitney U test.</p><p><sup>§</sup>The age of mice in this paper was P45-90 and measurements were done in S1.</p><p>However, the reviewer is right in pointing that in vivo recordings were obtained in adult animals. Moreover, we agree with the reviewer that it is important to determine whether this phenotype is transitory or if it lasts into adulthood. We shared this view, and indeed, we had started to record from adult animals, but we were forced to suspend all experiments and sacrifice our mouse colonies due to the current pandemic crisis in France. We are in the process of obtaining new colonies specifically for these experiments. In the following months, we will test the hypothesis of delayed development to be exploited in a future study that will include cross-disciplinary approaches.</p><disp-quote content-type="editor-comment"><p>3) in vivo field potentials. The field potential analysis is only loosely connected to the rest of the paper. How do we know whether “alterations in cortical GABA circuits underlie the abnormal network activity” and increased γ-power in the in vivo LFPs? Furthermore, the authors discuss these data in the context of temporal coding and cognition. The slow waves during urethane anesthesia (1-4Hz) resembles slow wave sleep, which is relevant for memory consolidation. The authors should discuss the new paper by Alemany-Gonzalez et al., 2020 (PNAS 117:11788-11798), which show disturbed slow wave sleep oscillations in Ts65Dn mice. Similar to the present study they find increased γ power in PFC during slow wave sleep (Alemany-Gonzalez, Figure 2B), which could be related to the well-known sleep disturbances in DS patients.</p></disp-quote><p>The reviewer raises a series of good points. We cannot directly link the inhibitory circuit-specific alterations that we detect in slices with the increased synchronization of β-γ-activity we see in vivo. However, a large body of literature indicates that oscillations in this frequency range strongly depends on the activity of PV cells (Buzsaki and Wang, 2012; Sohal et al., 2009; Cardin et al., 2009). More recently, also SST interneurons were shown to be involved in low frequency (30 Hz) neocortical γ-oscillations (Veit et al., 2017). Here, we find evidence for over-inhibition in Ts mice in vivo, accompanied by LFP power increases in β-γ-frequency ranges. These observations are consistent with increased interneuron activity (Cardin et al., 2009; Sohal et al., 2009; Atallah et al., 2012). Future studies will be necessary to identify the specific roles played by PV interneurons and MCs in controlling PN spiking in vivo its temporal correlation with network oscillations in Ts mice. These studies will be lengthy, as they will require controlling PV or MC firing using pharmacogenetics. We have better discussed this in the revised manuscript (Discussion section).</p><p>We agree with the reviewer that our results are more pertinent with slow-wave sleep and memory consolidation. We have revised our interpretation throughout the manuscript. We have also cited the recent report by Alemany-González et al., 2020, which showed increased low β- and γ-band during sleep and disrupted functional connectivity between the PFC and the hippocampus during learning in Ts65Dn mice.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>The authors present a clearly written, technically sound and very interesting study in which they demonstrate substantial changes in the prefrontal cortex inhibitory circuitry of a well-characterized transgenic Down Syndrome model. They show an aberrant dendritic inhibitory circuitry caused by an increased in synaptic transmission from and to Martinotti cells in the medial prefrontal cortex and changes in excitability of perisomatic inhibitory interneurons without apparent changes in synaptic properties. Finally, they demonstrate a strong decrease in principal cell activity on the medial prefrontal cortex of urethane anesthetized Ts mice and increase coupling to γ oscillations.</p><p>I find the study interesting and suitable for publication in eLife. It gives a detailed description of the inhibitory circuitry in the Ts mice and provides new in vivo evidence supporting the theory of over-inhibition as a main cause for cognitive deficits in DS. Nevertheless, there are some issues I think should be addressed first.</p><p>1) There is a mismatch between the age of animals used for in vitro and in vivo recordings. Down syndrome is a developmental disease, and it could be that interneuron development might take more time than in WT animals. PV positive interneurons are known to develop in the hippocampus during the first 4 postnatal weeks, bringing the question if the abnormalities observed in this study remain during adulthood. I suggest performing some of the main in vitro experiments for parvalbumin and somatostatin interneurons in slices from adult animals.</p></disp-quote><p>This is an excellent point that was similarly raised by reviewer #2. Please see the response to his point 2. We have re-analyzed our data, indicating that active and passive properties of PV cells in control animals were similar to those recorded in adults (Okaty et al., 2009 and Kaiser et al., 2016; see <xref ref-type="table" rid="resptable1">Author response table 1</xref>). However, we agree with the reviewer that it is important to determine whether the phenotypes observed are transitory or if they last throughout adulthood. We shared this view, and indeed, we had started to record from adult animals (X98 crossed with Ts65Dn and PvalbTdTomato crossed with Ts65Dn), but we were forced to suspend all experiments and sacrifice the mice due to the current pandemic crisis in France. We are in the process of obtaining new colonies specifically for these experiments in &gt;P70 mice. In the following months, we will be able to test the hypothesis of delayed development of PV cells. Results will be exploited in a future study that will include cross-disciplinary approaches. We have discussed this possibility in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>2) Another concern relates to the final conclusion of the paper, which correlates the in vitro observed abnormalities in inhibition with the decreased activity of principal cells. Although this might be the most rational assumption, I would appreciate evidence to make this hypothesis more likely, considering that DS mice also show changes in spine density, NMDA receptor expression in principal cells and increase threshold for firing as shown in this study. This could be performed by:</p><p>– Evaluating the effect of α5IA injection on principal cell activity in Eu and Ts mice.</p><p>– Performing recordings from identified interneurons in vivo in Eu and Ts mice.</p><p>– Test the effects of specific inhibition of parvalbumin or somatostatin interneurons on the activity of pyramidal cells in Eu and Ts mice.</p><p>A more comprehensive discussion addressing these issues might also be sufficient in case experiments are not feasible in a reasonable time frame.</p></disp-quote><p>The reviewer raises an excellent point. Please see our response to point 3 of Rev. #2, who raised a similar concern. In particular, we agree with the reviewer that what he/she proposes would be excellent experiments to complement and corroborate our conclusions. However, as detailed above, we are presently in a position that we cannot start even the easiest experiments before six months. In particular, 2-photon assisted recordings from identified interneurons cannot be performed in the mPFC, as it is too deep to allow 2P imaging. We would need to record from identified interneurons using either photo-tagging or GRIN-lens techniques, both of which will take several months to be implemented. Likewise, properly controlled chemogenetic manipulations of specific interneuron populations in vivo will require many months of work and substantial controls. We have therefore discussed more thoroughly the correlation between our in vivo and in vitro experiments in the revised manuscript, highlighting the limitations of our dataset.</p><disp-quote content-type="editor-comment"><p>3) The concentration of α5IA of 100 nm seems not to provide the highest specificity of the drug, having a milder but significant effect in receptors containing the α3 and α1 subunits (Dawson et al., 2005). Considering the general importance that this strong and very specific effect may have for the community, and the sparse literature using this drug in vitro I would appreciate a better characterization of this particular experiment.</p><p>– Does α5IA changes the kinetics of the GABAergic response?</p><p>– Are PV-mediated IPSCs affected by this concentration of α5IA?</p></disp-quote><p>The reviewer raises a good concern. However, we are confident that we are blocking α5-GABA<sub>A</sub>Rs selectively. Indeed, in Table 2 of Sternfeld et al., 2004, compound 16 corresponding to α5IA shows -29%, -4% and +4% efficacy at α5, α1 and α3-expressing GABA<sub>A</sub>Rs respectively. In addition, Figure 3 of Dawson et al. indicates that α5-IA at 100nM has less than 10% effect with recombinant α3-expressing GABA<sub>A</sub>Rs and around 15% effect for α1-containing GABA<sub>A</sub>Rs while the effect was above 40% for α5-expressing GABA<sub>A</sub>Rs. Moreover, PV-mediated IPSCs were not affected by this concentration of α5IA in control mice.</p><p>To assess a possible effect of the drug on the kinetics of synaptic responses we quantified rise and decay time constants (taus) in the presence and absence of α5IA in the bath. The drug did not affect uIPSC kinetics in both genotypes. Representative uIPSCs traces and population are shown in <xref ref-type="fig" rid="sa2fig2">Author response image 2</xref>, and indicated in the revised manuscript (Results section).</p><fig id="sa2fig2"><label>Author response image 2.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58731-resp-fig2-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>– Does the α5IA dependent response shows voltage-dependency as has been reported (Schultz et al., 2019)</p></disp-quote><p>We did not test voltage-dependency of the α5IA, as this drug was already characterized at dendritic inhibitory synapses (e.g. Schulz et al., 2018; Ali and Thomson, 2008). The experiments with this drug were not central to the core findings of our manuscript (namely inhibitory circuit-specific alterations in Ts mice). In general, however, voltage-dependency on dendrite-targeting synaptic responses can be problematic due to known space-clamp issues.</p></body></sub-article></article>